| Description | Chemical ligand-receptor interactions curated by experts |
| Measurement | association by literature curation |
| Association | receptor-ligand (chemical) associations by expert curation |
| Category | physical interactions |
| Resource | Guide to Pharmacology |
| Citation(s) | |
| Last Updated | 2015 Apr 06 |
| Stats |
|
| API | |
| Script | |
| Downloads |
Gene Similarity
Attribute Similarity
Gene Attribute
4893 sets of receptors of ligands (chemical) from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
| Gene Set | Description |
|---|---|
| PETCM | |
| McN-A-343 | |
| betaxolol | A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydoxy is substituted by a 4-[2-(cyclopropylmethoxy)ethyl]phenyl group and one of the hydrogens attached to the amino group is substituted by isopropyl. It is a selective beta1-receptor blocker and is used in the treatment of glaucoma as well as hypertension, arrhythmias, and coronary heart disease. It is also used to reduce non-fatal cardiac events in patients with heart failure. |
| glucagon-(1-21) | |
| dimaprit | An imidothiocarbamic ester that has formula C6H15N3S. |
| T134 | |
| telmisartan | |
| compound 11c [PMID:17929793] | |
| 22R-hydroxycholesterol | |
| 2-hydroxyoctanoic acid | |
| nitrooleic acid | |
| argatroban | An alpha-N-substituted L-arginine that has formula C23H36N6O5S. |
| [<sup>3</sup>H]BWA868C | |
| methyltyrosine | |
| VUF 5207 | |
| compound 11q [PMID:19433355] | |
| ibodutant | |
| [<sup>18</sup>F]MK-1312 | |
| [<sup>3</sup>H]AZ11637326 | |
| VU0364739 | |
| NPY-(2-36) | |
| [D-Ala<sup>2</sup> F<sub>5</sub> Phe<sup>4</sup>]dynorphin-(1-13)-NH<sub>2</sub> | |
| PSB-10 | |
| (2R)-N-[(2S)-1-[(4-carbamimidoylphenyl)methylamino]-3-hydroxy-1-oxopropan-2-yl]-3-hydroxy-2-(phenylmethylsulfonylamino)propanamide | |
| lamotrigine | A member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6. |
| acetyldigitoxin | |
| MCL0129 | |
| UR-PG131A | |
| phenylacetylrinvanil | |
| idelalisib | A member of the class of quinazolines that is 5-fluoro-3-phenylquinazolin-4-one in which the hydrogen at position 2 is replaced by a (1S)-1-(3H-purin-6-ylamino)propyl group. used for for the treatment of refractory indolent non-Hodgkin's lymphoma and relapsed chronic lymphocytic leukemia. |
| eGlu | |
| C2-NPY (pig) | |
| vincamine | |
| H-c[Cys-Phe-LAgl(N<sup>β</sup>Me benzoyl)-Trp-Lys-Thr-Phe-Cys]-OH | |
| RS-504393 | |
| FPRL1-inhibitor protein | |
| Gue1654 | |
| demotate 2 | |
| [<sup>125</sup>I]KC-Tyr | |
| entinostat | |
| L-888 291 | |
| [<sup>3</sup>H]S-15535 | |
| slotoxin | |
| MEN 10376 | |
| [<sup>3</sup>H]SNAP-7941 | |
| (+)-S20 | |
| (3R 5R)-7-(5-{[(4-cyanophenyl)methyl]carbamoyl}-3-(4-fluorophenyl)-4-phenyl-1-(propan-2-yl)-1H-pyrrol-2-yl)-3 5-dihydroxyheptanoate | |
| [<sup>3</sup>H]resolvin E1 | |
| kurtoxin | |
| SR146131 | |
| immepip | A piperidine that has formula C9H15N3. |
| (E)-N-[(3E)-4 8-dimethylnona-3 7-dien-1-yl]-N-methyl-N'-[(2E 6E)-3 7 11-trimethyldodeca-2 6 10-trien-1-yl]methenimidamide | |
| [1-bromo-(3S)-hydrox-4-(palmitoyloxy)butyl]phosphate | |
| {[(3-{[(3E)-4 8-dimethylnona-3 7-dien-1-yl](methyl)amino}propoxy)(hydroxy)phosphoryl]oxy}phosphonic acid | |
| galanin(2-30) (human) | |
| PnTx-3-6 | |
| RO4988546 | |
| Z-VDVAD-FMK | |
| [Tyr<sup>34</sup>]PTH-(3-34)-NH<sub>2</sub> (human) | |
| RS 67333 | |
| Ro67-7476 | |
| (R)-NFPS | |
| JV-1-40 | |
| [<sup>11</sup>C]DTBZ | |
| afamelanotide | |
| methyl-piperidino-pyrazole | |
| cholesterol | |
| GR 125 743 | |
| [<sup>125</sup>I]EYF | |
| 3-N<sub>3</sub>-Phpa-LVA | |
| cyclorelix | |
| L-765314 | |
| imbutamine | |
| phenamil | |
| Lys-kallidin | |
| BEL | |
| BAY607550 | |
| L-748337 | |
| thio-BCTC | |
| 10 10-difluoro TXA<sub>2</sub> | |
| Flu-CCL3 | |
| compound 1754-31 | |
| lauric acid | A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil. |
| [<sup>125</sup>I]buserelin | |
| methyltrienolone | |
| ethopropazine | |
| P'-geranyl 3 5 8-trihydroxy-3-methyloctanate 8-diphosphate | |
| enalaprilat | |
| miglustat | |
| aminooxyacetic acid | |
| apicidin | |
| [<sup>3</sup>H]ICI-198615 | |
| d[Cha<sup>4</sup>]LVP | |
| ABT-491 | |
| compound 30 [PMID: 21757343] | |
| tedisamil | |
| AZD9668 | |
| (1S 3Z)-3-{2-[(1R 3aS 7aR)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-octahydro-1H-inden-4-yl]ethylidene}-4 4-dimethylcyclohexan-1-ol | |
| rivastigmine | |
| (3R 5S 6E)-7-[2 4-bis(4-fluorophenyl)-5-(propan-2-yl)-1H-imidazol-1-yl]-3 5-dihydroxyhept-6-enoate | |
| LTE<sub>4</sub> | |
| [<sup>125</sup>I][Tyr<sup>8</sup>]bradykinin | |
| L-lactic acid | |
| [<sup>3</sup>H]SR142 801 | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Val<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| CyPPA | |
| Ins(3 4 5 6)P<sub>4</sub> | |
| fMet-Ile-Val-Ile-Leu | |
| AMI-1 | |
| palifermin | |
| linopirdine | An indole that has formula C26H21N3O. |
| [<sup>3</sup>H]RS 57639 | |
| RS 100235 | |
| [<sup>3</sup>H]NPC17731 | |
| darifenacin | |
| 15-deoxy-Δ<sup>12 14</sup>-PGD<sub>2</sub> | |
| SB-334867 | |
| astressin | A 30-membered homodetic cyclic peptide comprising the sequence D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Glu-Ala-His-Lys-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 cyclised by an amide bridge, formed by condensation of the side-chain carboxy group of the Glu residue at position 19 and the side-chain amino group of the Lys residue at posoition 22. |
| cinacalcet | |
| WS-23 | |
| gefitinib | |
| 5-HT-moduline | |
| RS-17053 | |
| ZM-274773 | |
| 5-methyl-​5-(5-meth​ylthiophe​n-3-yl)-4​-oxo-4 5-​dihydrofu​ran-2-car​boxylic a​cid | |
| quadazocine | |
| E913 | |
| <i>N</i>-desmethylclozapine | |
| ethanol | A primary alcohol that is ethane in which one of the hydrogens is substituted by a hydroxy group. |
| SDZ SER-082 | |
| naproxen | A methoxynaphthalene that is 2-methoxynaphthalene substituted by a carboxy ethyl group at position 6. Naproxen is a non-steroidal anti-inflammatory drug commonly used for the reduction of pain, fever, inflammation and stiffness caused by conditions such as osteoarthritis, kidney stones, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, menstrual cramps, tendinitis, bursitis, and for the treatment of primary dysmenorrhea. It works by inhibiting both the COX-1 and COX-2 enzymes. |
| batrachotoxin | A steroid that has formula C31H42N2O6. |
| phlorizin | An aryl beta-D-glucoside that is phloretin attached to a beta-D-glucopyranosyl residue at position 2' via a glycosidic linkage. |
| ONO-AE1-329 | |
| [<sup>18</sup>F](R R)-quinuclidinyl-4-fluoromethyl-benzilate | |
| [<i><sup>t</sup></i>Bu-D-Gly<sup>5</sup>]NPS | |
| dihydroergotamine | Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension. |
| PTHrP-(1-20)/TIP-(23-39) (human) | |
| amiloride | A monocarboxylic acid amide that is N-carbamimidoylpyrazine-2-carboxamide substituted by amino groups at positions 3 and 5 and a chloro group at position 6. |
| phenelzine | |
| xylometazoline | |
| phosphatidylserine | |
| [<sup>32</sup>P]MRS2500 | |
| macitentan | A member of the class of sulfamides in which the two amino groups of sulfonamide are substituted by 5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl and propyl groups. An orphan drug used for the treatment of pulmonary arterial hypertension. |
| adalimumab | |
| iodophenpropit | |
| [<sup>125</sup>I]glucagon (human mouse rat) | |
| ABT-384 | |
| norzotepine | |
| fMet-Leu-Phe-Glu | |
| BRL 44408 | |
| {5-[(4-phenyl-1 2 5-oxadiazol-3-yl)oxy]-1-phosphonopentyl}phosphonic acid | |
| SB269970 | |
| tonapofylline | |
| 5-benzyloxytryptamine | |
| PTH-(1-34) (rat) | |
| vestipitant | |
| (1S 2S 3S 5R)-1-(carboxymethyl)-3 5-bis({[(4-phenoxyphenyl)methyl](propyl)carbamoyl})cyclopentane-1 2-dicarboxylic acid | |
| compound 42 [PMID:22545772] | |
| quinidine | A cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy. |
| azathioprine | A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS. |
| AB-NECA | |
| 3-bicyclo[2.2.1]hept-2-yl-benzene-1 2-diol | |
| taprostene | |
| 3-phenyl-CPP | |
| (+)-JQ1 | |
| [<sup>3</sup>H]clidinium | |
| [His<sup>4</sup> Tyr<sup>5</sup> Trp<sup>6</sup> His<sup>7</sup>]TIP39 (human) | |
| PBMC | |
| [D-Trp<sup>32</sup>]NPY | |
| ivabradine | |
| MMPIP | |
| farnesyl thiodiphosphate | |
| Ro-70-0004 | |
| [<sup>18</sup>F]fluoroethylflumazenil | |
| sermorelin | |
| GIP-(6-30)-amide | |
| farnesyl monophosphate | |
| (-)-(<i>R</i>)-efonidipine | |
| [Sar<sup>1</sup> D-Ala<sup>12</sup>]galanin(1-16) | |
| HU-210 | |
| AH6809 | |
| fenoldopam | A benzazepine that has formula C16H16ClNO3. |
| Gal-B2-C<sub>12</sub> | |
| [<sup>3</sup>H]PAF | |
| DW13.3 | |
| NS11757 | |
| [<sup>125</sup>I]CNP (human) | |
| meloxicam | |
| TUG-424 | |
| DIDS | |
| <i>N</i>-α-Ac-PYY-(22-36) (rat) | |
| histrelin | |
| chlorthalidone | An isoindole that has formula C14H11ClN2O4S. |
| PD136450 | |
| Mg<sup>2+</sup> | |
| GW4064 | A stilbenoid that has formula C28H22Cl3NO4. |
| <i>N</i>-methyl-Phe-Lys-Pro-<small>D</small>-Cha-Cha-<small>D</small>-Arg-CO<sub>2</sub>H | |
| ciprofibrate | |
| chlorpromazine | A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety. |
| KT 5720 | |
| SB 699551 | |
| GV196771A | |
| dynorphin-(1-17)-NH<sub>2</sub> | |
| (3S 5R)-7-[(1S 2S 6R 8R)-2 6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1 2 6 7 8 8a-hexahydronaphthalen-1-yl]-3 5-dihydroxyheptanoate | |
| metolazone | |
| arecoline | A tetrahydropyridine that is 1,2,5,6-tetrahydropyridine with a methyl group at position 1, and a methoxycarbonyl group at position 3. An alkaloid found in the areca nut, it acts as an agonist of muscarinic acetylcholine. |
| digeranyl bisphosphonate | |
| (1S 2S 3S 4S)-3 4-bis[(2-methylpropyl)[(4-phenoxyphenyl)methyl]carbamoyl]cyclobutane-1 2-dicarboxylic acid | |
| compound 23c [PMID:17929793] | |
| TC-2559 | |
| rifampicin | A rifamycin that is a a semisynthetic antibiotic derived from Amycolatopsis rifamycinica (previously known as Amycolatopsis mediterranei and Streptomyces mediterranei) |
| ambrisentan | |
| dioleoylphosphatidic acid | A phosphatidic acid in which the phosphatidyl acyl groups are both oleoyl. |
| tegaserod | |
| SSR125543A | |
| bantag-1 | |
| SLIGRL-NH<sub>2</sub> | |
| NNC-711 | |
| kisspeptin-28 | |
| [<sup>3</sup>H]NGD941 | |
| SNAP-5114 | |
| AL-37350A | |
| [Leu<sup>9</sup> des-Arg<sup>10</sup>]kallidin | |
| chlorzoxazone | A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm. |
| (4R 6S)-6-[(E)-2-[6-chloro-4-(4-fluorophenyl)-2-(propan-2-yl)quinolin-3-yl]ethenyl]-4-hydroxyoxan-2-one | |
| UCCF-853 | |
| T-0632 | |
| acetylcholine | |
| capsaicin | A capsaicinoid that has formula C18H27NO3. |
| des-His<sup>1</sup>-[Leu<sup>4</sup>-Glu<sup>9</sup>]glucagon-NH<sub>2</sub> | |
| RO330-0802/001 | |
| ω-phonetoxin-IIA | |
| DAU 6285 | |
| (3R)-4-{[(E)-2-[5-ethyl-4-(4-fluorophenyl)-6-phenyl-2-(propan-2-yl)pyridin-3-yl]ethenyl]phosphinato}-3-hydroxybutanoate | |
| tivozanib | |
| OPC-51803 | |
| fludarabine | |
| quetiapine | A dibenzothiazepine that has formula C21H25N3O2S. |
| DPC | |
| 4-DAMP | |
| indoramin | |
| fMet-Leu-Phe | |
| VU0404251 | |
| prunetin | A hydroxyisoflavone that is genistein in which the hydroxy group at position 7 is replaced by a methoxy group. |
| LSP1-2111 | |
| Des-AA<sup>5</sup>-[D-Trp<sup>8</sup>]SRIF | |
| L-759 633 | |
| CYM5181 | |
| [<sup>125</sup>I]tertiapin Y1/K12/Q13 | |
| JNJ-10311795 | |
| SNX482 | |
| perphenazine | A member of the class of phenothiazines that is phenothiazine having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position. |
| α-ergocryptine | Ergotaman bearing hydroxy, isopropyl, and 2-methylpropyl groups at the 12', 2' and 5' positions, respectively, and oxo groups at positions 3', 6', and 18. It is a natural ergot alkaloid. Ergocryptine discussed in the literature prior to 1967, when beta-ergocryptine was separated from alpha-ergocryptine, is now referred to as alpha-ergocryptine. |
| [Tyr<sup>34</sup>]GLP-2 (human) | |
| saxitoxin | An alkaloid isolated from the marine dinoflagellates and cyanobacteria that causes paralytic shellfish poisoning. |
| [<sup>3</sup>H]QNB | |
| pCMPS | |
| [Leu<sup>14</sup> ψ 13-14)]bombesin | |
| propafenone | An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias. |
| compound 26 [PMID:16190743] | |
| roxithromycin | |
| d[Leu<sup>4</sup>]AVP | |
| FAUC213 | |
| seocalcitol | |
| apamin | |
| GSK-J1 | |
| GSK4716 | A monoterpenoid that has formula C17H18N2O2. |
| GlyH-101 | |
| galanin(5-29) (rat/mouse) | |
| [<sup>3</sup>H]NECA | |
| [<sup>125</sup>I]1DMe | |
| ErgTx-1 | |
| succinylcholine | A quaternary ammonium ion that is the bis-choline ester of succinic acid. |
| burimamide | An imidazole that has formula C9H16N4S. |
| pralnacasan | |
| 5-MPEP | |
| [<sup>125</sup>I]Tyr<sup>10</sup>NPS (human) | |
| (3R 6E)-7-[6-tert-butyl-4-(4-fluorophenyl)-2-(propan-2-yl)pyridin-3-yl]-3 5-dihydroxyhept-6-enoate | |
| alcuronium | |
| compound 12e [PMID: 22266036] | |
| Δ<sup>9</sup>-tetrahydrocannabinol | |
| 2 4 diahexanxoylphloroglucinol | |
| aliskiren | |
| camostat | |
| vCXCL-1 | |
| vMIP-II | |
| [<sup>125</sup>I]CHIPS | |
| compound 26a [PMID: 16242323] | |
| methyl (3R 5S 6E)-7-[3-bromo-4 5-bis(4-fluorophenyl)-2-(propan-2-yl)-1H-pyrrol-1-yl]-3 5-dihydroxyhept-6-enoate | |
| 5-oxo-ETE | An oxoicosatetraenoic acid having a 5-oxo group; and (6E)-, (8Z), (11Z)- and (14Z)-double bonds. |
| [Thi<sup>5 8</sup> D-Phe<sup>7</sup>]bradykinin | |
| JMV457 | |
| CCPA | |
| [<sup>125</sup>I][Tyr<sup>5</sup> DAla<sup>6</sup> NMeLeu<sup>7</sup> Pro<sup>9</sup>-NEt]GnRH | |
| CHIPS-(28-149) | |
| kassinin | |
| CITCO | |
| R-715 | |
| CHPG | |
| 3-hydroxy capric acid | |
| impentamine | |
| L-alanine | The L-enantiomer of alanine. |
| taprenepag | |
| IN-3 | |
| letrozole | A triazole that has formula C17H11N5. |
| [<sup>3</sup>H]flunitrazepam | |
| SCH 58261 | |
| pirinixic acid | An aryl sulfide that has formula C14H14ClN3O2S. |
| PIP<sub>2</sub> | |
| tyramine | |
| compound 8 [PMID: 15482908] | |
| MRK016 | |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-6-{[(decyloxy)carbonyl]oxy}-4 7-dihydroxy-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| (3R)-3-hydroxy-5-oxo-7-phenylheptanoic acid | |
| pargyline | |
| zaprinast | |
| CP734432 | |
| ATLa2 | |
| 2-hydroxy-saclofen | |
| noxiustoxin | |
| <i>N</i>-1-isopropyltryptamine | |
| chemerin C-terminal peptide | |
| sibutramine | |
| 4-{[3-({[(2E)-6 6-dimethylhept-2-en-4-yn-1-yl](ethyl)amino}methyl)phenoxymethyl]dimethylsilyl}benzonitrile | |
| CXCL12-(1-17) | |
| [<sup>125</sup>I]CCL11 (human) | |
| [Ala<sup>1 12</sup> Aib<sup>3</sup> Gln<sup>10</sup> hArg<sup>11</sup> Trp<sup>14 </sup>Arg<sup>19</sup>]PTH-(1-21)-NH2 (human) | |
| [<sup>14</sup>C]TEA | |
| BIM 23056 | |
| ONO-AE5-599 | |
| Br-5MPEPy | |
| TAK-652 | |
| BIM 23068 | |
| BIM 23059 | |
| compound 1 [PMID: 22465637] | |
| (4R)-6-{2-[2-ethyl-4-(4-fluorophenyl)-6-phenylpyridin-3-yl]ethyl}-4-hydroxyoxan-2-one | |
| L-368 899 | |
| NS1738 | |
| BIM 23060 | |
| (-)-menthol | |
| [<sup>3</sup>H]CGP61594 | |
| quinpirole | A pyrazoloquinoline that is (4aR,8aR)-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinoline substituted by a propyl group at position 5. It acts as a dopamine agonist. |
| BIM 23066 | |
| DAVP | |
| benzolamide | |
| mequinol | |
| vatalanib | |
| desmopressin | A synthetic analogue of vasopressin in which 3-mercaptopropionic acid replaces the cysteine residue at position 1 and D-arginine replaces the residue at position 8. An antidiuretic, it increases urine concentration and decreases urine production, and is used (usually as the trihydrate of the acetic acid salt) to prevent and control excessive thirst, urination, and dehydration caused by injury, surgery, and certain medical conditions. It is also used in the diagnosis and treatment of cranial diabetes insipidus and in tests of renal function. |
| [<sup>3</sup>H]M-MPEP | |
| BMS641 | |
| LY-288513 | |
| t-Boc-FLFLF | |
| IBMX | An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively. |
| metrifudil | |
| [<sup>125</sup>I]CCL7 (human) | |
| [<sup>125</sup>I]α-DTX | |
| Ro4491533 | |
| celecoxib | |
| MZ-5-78 | |
| MRS2927 | |
| [<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup> Orn<sup>8</sup> Tyr-NH<sub>2</sub><sup>9</sup>]OVT | |
| 4-oxo-nonenal | |
| [<sup>3</sup>H]CGS23131 | |
| acetic acid | A simple monocarboxylic acid containing two carbons. |
| oxazine 89 | |
| VU0361737 | |
| 5-Me-IAA | |
| 3-[(E)-2-(4-phenylphenyl)ethenyl]-1-azabicyclo[2.2.2]octane | |
| gentamicin | |
| 4-[3-(dodeca-1 3-diyn-1-yl)oxiran-2-yl]butanoic acid | |
| ECDCA | |
| 4-MPPTS | |
| SIB-1757 | |
| Ro15-4513 | |
| pipamperone | |
| [Ac-His<sup>1</sup>]PACAP-27 | |
| SKF-83556 | |
| L-367 773 | |
| ZK-158252 | |
| [<sup>3</sup>H]methyllycaconitine | |
| [<sup>3</sup>H]taurocholic acid | |
| aspirin triggered lipoxin A4 | |
| UDP-glucose | |
| 3-hydroxyoctanoic acid | An 8-carbon, beta-hydroxy fatty acid which may be a marker for primary defects of beta-hydroxy fatty acid metabolism. Repeating unit of poly(3-hydroxyoctanoic acid), a biopolymer used by numerous bacterial species as carbon and energy reserves. |
| MK-2894 | |
| cetirizine | A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively. |
| galanin(9-29) (rat/mouse) | |
| [<sup>125</sup>I]CRF (ovine) | |
| allyl isothiocyanate | An isothiocyanate with the formula CH2=CHCH2N=C=S. A colorless oil with boiling point 152degreeC, it is responsible for the pungent taste of mustard, horseradish, and wasabi. |
| 2-arachidonoylglycerol | An endocannabinoid and an endogenous agonist of the cannabinoid receptors (CB1 and CB2). It is an ester formed from omega-6-arachidonic acid and glycerol. |
| [<sup>3</sup>H]gabazine | |
| Lu AF21934 | |
| compound 34 [PMID: 20409708] | |
| [βAla<sup>8</sup>]neurokinin A-(4-10) | |
| Rec 15/3079 | |
| brucine <i>N</i>-oxide | |
| strychnine | |
| Cl-IB-MECA | |
| [Ile<sup>5</sup> Trp<sup>23</sup>]PTHrP-(3-36) (human) | |
| dipropyl-5-CT | |
| Rb<sup>+</sup> | |
| DOTA-BASS | |
| (3R)-6-{[2-(4-fluorophenyl)-4-(propan-2-yl)quinolin-3-yl]oxy}-3 5-dihydroxyhexanoate | |
| [Arg<sup>14</sup>Lys<sup>15</sup>]N/OFQ | |
| dimethylethylamine | |
| CGP 20712A | |
| meclizine | |
| {2-[3-(decyloxy)phenyl]-1-hydroxy-1-phosphonoethyl}phosphonic acid | |
| R-138727 | |
| [D-Arg<sup>1</sup> D-Trp<sup>7 9</sup> Leu<sup>11</sup>]substance P | |
| L-054 522 | |
| [Tyr<sup>8</sup>]bradykinin | |
| HMA | |
| 1 2 3-benzenetricarboxylic acid | |
| INS50589 | |
| FK-453 | |
| gingerol | A beta-hydroxy ketone that is 5-hydroxydecan-3-one substituted by a 4-hydroxy-3-methoxyphenyl moiety at position 1; believed to inhibit adipogenesis. It is a constituent of fresh ginger. |
| azacitidine | |
| LY404187 | |
| MRS2768 | |
| L-ornithine | An optically active form of ornithine having L-configuration. |
| esmolol | A carboxylic ester that is methyl 3-(4-hydroxyphenyl)propanoate in which the hydrogen attached to the phenoic hydroxy group is substituted by a 2-hydroxy-3-(isopropylamino)propyl group. A cardioselective and short-acting beta1 receptor blocker with rapid onset but lacking intrinsic sympathomimetic and membrane-stabilising properties, it is used as the hydrochloride salt in the management of supraventricular arrhythmias, and for the control of hypertension and tachycardia during surgery. |
| metoclopramide | A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine. |
| halothane | A haloalkane comprising ethane having three flouro substituents at the 1-position as well as bromo- and chloro substituents at the 2-position. |
| 5-oxo-ODE | |
| MRE 3010F20 | |
| [Ala<sup>6</sup> D-Trp<sup>8</sup>]galanin-(1-15)-ol | |
| ML169 | |
| (±)-<i>trans</i>-H<sub>2</sub>-PAT | |
| PCA 4248 | |
| dodecylphosphate | |
| 2MeSADP | |
| RHC80267 | |
| SQ-34919 | |
| T<sub>3</sub> | |
| FMS586 | |
| XCC | |
| PS020990 | |
| S24014 | |
| (S)-3-hydroxy-3-methylglutaryl-CoA | An acyl-CoA oxoanion that results from the removal of all five protons from the phosphate and carboxylic acid groups of (3S)-3-hydroxy-3-methylglutaryl-CoA. |
| [<sup>125</sup>I]ANP | |
| alkyl glycerol phosphate 18:1 | |
| [<sup>3</sup>H]maraviroc | |
| AGN194204 | |
| [<sup>3</sup>H]2MeSADP | |
| <i>N</i>-α-methylhistamine | |
| ONO-AE2-227 | |
| UVI3003 | |
| ezlopitant | |
| gevokizumab | |
| uPar fragment | |
| ischemin | |
| o-hydroxyatorvastatin | |
| zaleplon | A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position. |
| J20 (galanin analogue) | |
| TCPA | |
| PSN375963 | |
| ZK93426 | |
| CT-(8-32) (salmon) | |
| succinic acid | |
| MRS2500 | |
| [Leu<sup>31</sup> Pro<sup>34</sup>]NPY | |
| CPI-203 | |
| [<sup>11</sup>C]SB207145 | |
| PD168 077 | |
| lexacalcitol | |
| M242 | |
| MRS2690 | |
| VUF5574 | |
| bilobalide | A terpenoid trilactone found in extracts of Ginkgo biloba. |
| clomipramine | A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias. |
| MM54 | |
| A804598 | |
| AD5075 | |
| fluvoxamine | A 5-methoxyvalerophenone O-(2-aminoethyl)oxime that has formula C15H21F3N2O2. |
| [<sup>125</sup>I]VIP | |
| ρ-Da1a | |
| L-βγ-meATP | |
| 5-(2-ethoxyethyl)-5-[4-(4-fluorophenoxy)phenoxy]-1 3-diazinane-2 4 6-trione | |
| galanin(2–29) (rat/mouse) | |
| HEMADO | |
| BIM 23027 | |
| ergometrine | A monocarboxylic acid amide that is lysergamide in which one of the hydrogens attached to the amide nitrogen is substituted by a 1-hydroxypropan-2-yl group (S-configuration). An ergot alkaloid that has a particularly powerful action on the uterus, its maleate (and formerly tartrate) salt is used in the active management of the third stage of labour, and to prevent or treat postpartum of postabortal haemorrhage caused by uterine atony: by maintaining uterine contraction and tone, blood vessels in the uterine wall are compressed and blood flow reduced. |
| NNC 11-1607 | |
| [<sup>3</sup>H]5-oxo-ETE | |
| [<sup>125</sup>I]CXCL10 | |
| 6-hydroxymelatonin | A member of the class of tryptamines that is melatonin with a hydroxy group substituent at position 6. |
| aminoguanidine | A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide. |
| gemfibrozil | An aromatic ether that has formula C15H22O3. |
| [<sup>125</sup>I]CXCL11 | |
| 3 5-dihydroxybenzoic acid | A dihydroxybenzoic acid in which the hydroxy groups are located at positions 3 and 5. |
| compound 41 [PMID: 23434029] | |
| H-c[Cys-Phe-LAgl(N<sup>β</sup>Me benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH | |
| ALX40-4C | |
| (1-phosphonato-4-{4-[4-(trifluoromethyl)phenyl]phenyl}butyl)phosphonate | |
| risperidone | A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2. |
| [D-Tyr<sup>8</sup>]CYN 154806 | |
| SQ 26655 | |
| meclinertant | |
| goserelin | |
| (+)-ADTN | |
| MZ-4-181 | |
| cinnamic acid | A monocarboxylic acid that consists of acrylic acid bearing a phenyl substituent at the 3-position. It is found in Cinnamomum cassia. |
| [<sup>125</sup>I]CT (salmon) | |
| CV-1808 | |
| [Leu<sup>31</sup> Pro<sup>34</sup>]NPY (pig) | |
| (3R 5R)-7-[(1S 2S 3R 6S)-2-{[(2 2-dimethylbutanoyl)oxy]methyl}-6-methyl-3-propylcyclohexyl]-3 5-dihydroxyheptanoic acid | |
| AZD9272 | |
| compound 22 [PMID: 17276684] | |
| GW0742X | |
| compound 9 (PMID: 23517011) | |
| group E 1682-2106 [PMID:16118363] | |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-4 7-dihydroxy-6-[(11-phenoxyundecyl)oxy]-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| mitotane | |
| (+)-aceclidine | |
| dATP | A purine 2'-deoxyribonucleoside 5'-triphosphate having adenine as the nucleobase. |
| methocarbamol | |
| meso-DAP | |
| VU0424465 | |
| compound 10 [PMID: 22533316] | |
| A425619 | |
| VPC32183 | |
| GSK1331268 | |
| [<sup>125</sup>I]CT (human) | |
| methyl isocyanate | Methane modified by a single isocyanato substituent. |
| compound 26b [PMID: 16242323] | |
| 5 7-dichlorokynurenic acid | |
| PD-135666 | |
| 7β 25-dihydroxycholesterol | |
| SC-50998 | |
| paxilline | An organooxygen compound that has formula C27H33NO4. |
| morphanthridine | |
| A-803467 | |
| compound 20o [PMID:22984835] | |
| L-362 823 | |
| <i>N</i>-[<sup>3</sup>H]methylhistamine | |
| PGD<sub>3</sub> | |
| compound 22 [PMID: 19289283] | |
| S 16924 | |
| α-conotoxin MII | |
| picrotin | A furopyran that has formula C15H18O7. |
| 2MD | |
| [<sup>3</sup>H]darifenacin | |
| HC067047 | |
| [Phe<sup>8</sup> <i>ψ</i>(CH<sub>2</sub>-NH)Arg<sup>9</sup>]BK | |
| ELND006 | |
| A134974 | |
| zoledronic acid | |
| 1-oleoyl glycerol | A 1-monoglyceride where the acyl group is oleoyl. |
| pergolide | A diamine that is ergoline in which the beta-hydrogen at position 8 is replaced by a (methylthio)methyl group and the hydrogen attached to the piperidine nitrogen (position 6) is replaced by a propyl group. A dopamine D2 receptor agonist which also has D1 and D2 agonist properties, it is used as the mesylate salt in the management of Parkinson's disease, although it was withdrawn from the U.S. and Canadian markets in 2007 due to an increased risk of cardiac valve dysfunction. |
| [<sup>3</sup>H]spiperone | |
| 3-[4-(thiophen-2-yl)phenyl]-octahydropyrido[2 1-c]morpholin-3-ol | |
| spantide I | |
| R3-B1-22R | |
| A740003 | |
| hexocyclium | |
| isoamylamine | |
| [Trp<sup>7</sup> β-Ala<sup>8</sup>] neurokinin A-(4-10) | |
| lintitript | |
| phencyclidine | A member of the class of piperidines that is piperidine in which the nitrogen is substituted with a 1-phenylcyclohexyl group. Formerly used as an anaesthetic agent, it exhibits both hallucinogenic and neurotoxic effects. |
| VU0364770 | |
| EISAI-1 | |
| [Leu<sup>31</sup> Pro<sup>34</sup>]PYY (pig) | |
| galmic | |
| bumetanide | A member of the class of benzoic acids that is 4-phenoxybenzoic acid in which the hydrogens ortho to the phenoxy group are substituted by butylamino and sulfamoyl groups. Bumetanide is a diuretic, and is used for treatment of oedema associated with congestive heart failure, hepatic and renal disease. |
| VUF8504 | |
| CGP 71872 | |
| L 755507 | |
| DC-EBIO | A dichlorobenzene that has formula C9H8Cl2N2O. |
| upamostat | |
| ginkgolide C | A diterpene lactone that has formula C20H24O11. |
| ginkgolide B | A diterpene lactone that has formula C20H24O10. |
| ginkgolide A | A diterpene lactone that has formula C20H24O9. |
| compound 24d [PMID: 23357634] | |
| clonazepam | 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation. |
| 12-epi LTB<sub>4</sub> | |
| methylphenidate | A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy. |
| sotalol | A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is sustituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias. |
| MZ-5-192 | |
| pregnenolone sulphate | |
| 9-anthroic acid | An anthroic acid carrying the carboxy substituent at position 9. |
| SKF-76783 | |
| jingzhaotoxin-XI | |
| farnesyl diphosphate | A farnesyl phosphate that has formula C15H28O7P2. |
| rivenprost | |
| [<sup>3</sup>H]pemetrexed | |
| compound 23h [PMID:17929793] | |
| acetaldehyde | The aldehyde formed from acetic acid by reduction of the carboxy group. It is the most abundant carcinogen in tobacco smoke. |
| RO4938581 | |
| dendrotoxin-1 | |
| abnormal cannabidiol | |
| ginkgolide X | |
| 2-arachidonyl glyceryl ether | |
| (R)-flurocarazolol | |
| PF-4840154 | |
| linifanib | |
| 2'-Me-CCPA | |
| (+)-MCPG | |
| (+)-butaclamol | An organic heteropentacyclic compound that is 2,3,4,4a,8,9,13b,14-octahydro-1H-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinoline substituted at position 3 by both hydroxy and tert-butyl groups. |
| SP203 | |
| resminostat | |
| polyIC | A mismatched double-stranded RNA with one strand being a polymer of inosinic acid, the other a polymer of cytidylic acid. |
| CH 275 | |
| 8S-HETE | A HETE having an (8S)-hydroxy group and (5Z)-, (9E)-, (11Z)- and (14Z)-double bonds. |
| BAY-73-1449 | |
| SNAP 398299 | |
| tafluprost | |
| d[Cha<sup>4</sup> Dab<sup>8</sup>]VP | |
| para-coumaric acid | |
| D-Nal Cys Tyr D-Trp Orn Val Cys Nal-NH<sub>2 </sub> | |
| compound 3 [PMID: 12470711] | |
| 2-methylhistamine | An aralkylamino compound that is histamine bearing a methyl substituent at the 2 position on the ring. |
| SB 242084 | |
| L-165041 | |
| [Ile<sup>31</sup> Gln<sup>34</sup>]PP (human) | |
| PP-(20-36) (human) | |
| glemanserin | |
| N<sup>ω</sup>propyl-L-arginine | |
| A-349821 | |
| compound 18 [PMID: 21927650] | |
| TPI 1361-17 | |
| relcovaptan | |
| cicloprolol | |
| sufinpyrazone | |
| FUB 349 | |
| R-L3 | A benzodiazepine that has formula C25H20FN3O. |
| chenodeoxycholic acid | A dihydroxy-5beta-cholanic acid that is (5beta)-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 7 respectively. |
| eburnamonine | An alkaloid that has formula C19H22N2O. |
| [<sup>3</sup>H]PSB-0413 | |
| [<sup>3</sup>H]rauwolscine | |
| SB236057 | |
| (-)-N-porphynorapomorphine | |
| LY379268 | |
| AZ505 | |
| (<i>S</i>)-cetirizine | |
| AS16 | |
| [<sup>3</sup>H]tiotidine | |
| L-779 976 | |
| MRS1505 | |
| PIP<sub>3</sub> | |
| ONO-AE3-240 | |
| CP-293019 | |
| sauvagine | |
| rosuvastatin | |
| cinnamaldehyde | The E (trans) stereoisomer of cinnamaldehyde, the parent of the class of cinnamaldehydes. |
| WIN 64338 | |
| R3(BΔ23-27)R/I5 chimeric peptide | |
| (+)-LSD | |
| BIM 23127 | |
| histaprodifen | |
| WAY-163909 | |
| TNP-ATP | A sprioketal resulting from the formal condensation of the 2'- and 3'- hydroxy groups of ATP with picric acid. |
| PF3845 | |
| norethisterone | A 17beta-hydroxy steroid that is testosterone in which the hydrogen at position 17 is replaced by an ethynyl group and in which the methyl group attached to position 10 is replaced by hydrogen. |
| eucalyptol | |
| daglutril | |
| H3-CoA-20 | |
| BAY 55-9837 | |
| OPC 4392 | |
| SQ-29548 | |
| pancuronium | A steroid ester in which a 5alpha-androstane skeleton is C-3alpha- and C-17beta-disubstituted with acetoxy groups and 2beta- and 16beta-disubstituted with 1-methylpiperidinium-1-yl groups. It is a non-depolarizing curare-mimetic muscle relaxant. |
| sufugolix | |
| [<sup>3</sup>H](Pyr<sup>1</sup>)[Met(0)11]-apelin-13 | |
| TAK-070 | |
| diethylstilbestrol | |
| RN1734 | |
| 6-Cl-MLT | |
| 3-MPPTS | |
| [<sup>3</sup>H]LTC<sub>4</sub> | |
| vincristine | A vinca alkaloid that has formula C46H56N4O10. |
| d[Cha<sup>4</sup>]AVP | |
| [<sup>125</sup>I]antisauvagine | |
| U75302 | |
| SIB-1893 | |
| formalin | |
| immethridine | |
| (4R)-6-{2-[4-(4-fluorophenyl)-6-phenyl-2-(propan-2-yl)pyridin-3-yl]ethyl}-4-hydroxyoxan-2-one | |
| d[Pen<sup>1</sup> Tyr(Me)<sup>2</sup>]AVP | |
| [D-Ala<sup>7</sup>]-angiotensin(1-7) | |
| RO5101576 | |
| LS-192629 | |
| compound 7 [PMID: 22533316] | |
| TAK 044 | |
| ximelagatran | A member of the class of azetidines that is melagatran in which the carboxylic acid group has been converted to the corresponding ethyl ester and in which the amidine group has been converted to the corresponding amidoxime. A prodrug for melagatran, ximelagatran was the first orally available direct thrombin inhibitor to be brought to market as an anticoagulant, but was withdrawn in 2006 following reports of it causing liver damage. |
| GW841819X | |
| GSK2210875 | |
| probenecid | |
| 7-epi-ginkgolide C | |
| tetrahydrodeoxycorticosterone | |
| lepirudin | |
| EP 171 | |
| NQN-1 | |
| [<sup>125</sup>I]DTyr-Gly-[(Nle28 31)CCK-26-33 | |
| naringin | |
| [<sup>3</sup>H]GlySar | |
| carveol | A limonene monoterpenoid that is cyclohex-2-en-1-ol substituted by a methyl group at position 2 and a prop-1-en-2-yl group at position 5. |
| isonipecotic acid | |
| salvinorin A | An organooxygen compound that has formula C23H28O8. |
| Pfizer compound 67 [PMID:18445527] | |
| diphenyltetrahydrofuran | |
| (-)-pindolol | A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol. |
| imipramine | A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom. |
| givinostat | |
| MRS1476 | |
| BOMA | |
| omeprazole | A racemate comprising equimolar amounts of (R)- and (S)-omeprazole. |
| [<sup>125</sup>I]kisspeptin-13 (human) | |
| selfotel | An alpha-amino acid that has formula C7H14NO5P. |
| M15 | |
| methoctramine | A tetramine that is N,N'-bis(6-aminohexyl)octane-1,8-diamine where the primary amino groups both carry 2-methoxybenzyl substituents. |
| [<sup>3</sup>H]melatonin | |
| compound 8g [PMID:21444206] | |
| spantide II | |
| netoglitazone | |
| MEL57A | |
| 5S-HPETE | An icosatetraenoic acid in which the double bonds are located at the 6-7, 8-9, 11-12, and 14-15 positions and have E, Z, Z, and Z geometry, respectively, and in which the pro-S hydrogen is substituted by a hydroperoxy group. |
| PKR-A | |
| compound 16 [PMID: 16242323] | |
| calcitonin (salmon recombinant) | |
| [<sup>125</sup>I][Phe<sup>13</sup> Tyr<sup>19</sup>]MCH | |
| ED-71 | |
| liraglutide | |
| 2-arachidonoylglycerolphosphoinositol | |
| SCH 57790 | |
| inositol 2 4 5-trisphosphate | |
| [<sup>111</sup>In <sup>90</sup>Y]DOTA-LAN | |
| <i>N</i>-desalkylquetiapine | |
| beta-ergocriptine | |
| BRD9539 | |
| banyu (I) | |
| <i>N</i>-ethylhistamine | |
| BWA868C | |
| miconazole | A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes. |
| [<sup>18</sup>F]ET-1 | |
| [<sup>3</sup>H]mesulergine | |
| [<sup>125</sup>I]H3-B/INSL5 A chimera | |
| dVDAVP | |
| BgK | |
| L-764406 | |
| [<sup>11</sup>C]flumazenil | |
| EFWSLAAPQRF-NH<sub>2</sub> | |
| clidinium | The ester resulting from formal condensation of benzilic acid and 3-hydroxy-1-methyl-1-azoniabicyclo[2.2.2]octane. It is used, generally as the bromide, for the symptomatic treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. |
| [<sup>3</sup>H]SCH-23390 | |
| (12E 20Z 18S)-8-hydroxyvariabilin | |
| allopurinol | A bicyclic structure comprising a pyrazole ring fused to a hydroxy-substituted pyrimidine ring. |
| D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub> | |
| ATL802 | |
| ranatensin | |
| PHA-709829 | |
| AS94 | |
| [<sup>125</sup>I]Tyr<sup>10</sup>-CST14 | |
| [<sup>125</sup>I]iodophenpropit | |
| galanin(9-25) (rat/mouse) | |
| 2-hydroxy capric acid | |
| NE58062 | |
| SLIGKV-NH<sub>2</sub> | |
| eribulin | |
| RGFP966 | |
| μ-conotoxin PIIIA | |
| phenylephrine | A member of the class of the class of phenylethanolamines that is 2-(methylamino)ethanol substituted by a 3-hydroxyphenyl group at position 1. |
| [<sup>125</sup>I]CGP 23996 | |
| GaTx1 | |
| roxindole | A ring assembly that has formula C23H26N2O. |
| GaTx2 | |
| chlorpheniramine | |
| AR-C67085 | |
| OH-LVA | |
| lysophosphatidylserine | An acylglycerophosphoserine resulting from partial hydrolysis of a phosphatidylserine, which removes one of the fatty acid groups. The structure is depicted in the image where R(1) = acyl, R(2) = H or where R(1) = H, R(2) = acyl. |
| triptorelin | |
| vMIP-I | |
| palonosetron | |
| MCH (salmon) | |
| lorcaserin | |
| SB705498 | |
| N N`-bis-alkyl butylimmidazole 12b | |
| FR167344 | |
| GR 63799 | |
| [<sup>3</sup>H]SR48 968 | |
| PFI-1 | |
| NPY-(13-36) (human) | |
| xamoterol | |
| [<sup>3</sup>H]LTB4 | |
| econazole | A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. |
| GR64349 | |
| prinomastat | |
| ML221 | |
| naltrindole | An isoquinoline that has formula C26H26N2O3. |
| HmTx2 | |
| FG-5893 | |
| compound 2b-1 [PMID: 12614873] | |
| HmTx1 | |
| phenytoin | A imidazolidine-2,4-dione that consists of hydantoin bearing two phenyl substituents at position 5. |
| ibotenate | |
| EIPA | |
| N<sup>4</sup>-phenylethoxycytidine-5′-triphosphate | |
| 7α-NHEt-ginkgolide B | |
| pimozide | |
| CP 99994 | |
| compound 3 [PMID: 9003518] | |
| NE97221 | |
| PD123319 | An imidazopyridine consisting of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine having 4-(dimethylamino)-3-methylbenzyl, diphenylacetyl and carboxy and groups at positions 1, 5 and 6 respectively |
| CPPZ | |
| BRL 37344 | |
| (R)-EF-1520 | |
| CPPG | |
| [<sup>111</sup>In]DOTA-NOC-ATE | |
| cyclo apelin-12 (1-12) | |
| phenobarbital | A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups. |
| PRL-2915 | |
| methazolamide | |
| buprenorphine | A morphinane alkaloid that is 7,8-dihydromorphine 6-O-methyl ether in which positions 6 and 14 are joined by a -CH2CH2- bridge, one of the hydrogens of the N-methyl group is substituted by cyclopropyl, and a hydrogen at position 7 is substituted by a 2-hydroxy-3,3-dimethylbutan-2-yl group. |
| prostaglandin A2 | A prostaglandins A that has formula C20H30O4. |
| (1S 3R 4R 4aR 7S 8S)-4-[(benzylcarbamoyl)oxy]-8-{2-[(4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3 7-dimethyl-decahydronaphthalen-1-yl 2 2-dimethylbutanoate | |
| [<sup>19</sup>Lys <sup>26</sup>Leu]-galparan | |
| compound 15 [PMID:18178086] | |
| tropisetron | |
| zofenopril | |
| MK-0493 | |
| piretanide | |
| N-palmitoylethanolamine | |
| LAS38096 | |
| [<sup>125</sup>I]exendin | |
| sBmTX 3 | |
| perindopril | An alpha-amino acid ester that is the ethyl ester of N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvaline |
| CP94253 | |
| compound 36 [PMID: 17936624] | |
| desloratadine | Loratadine in which the ethoxycarbonyl group attached to the piperidine ring is replaced by hydrogen. The major metabolite of loratidine, desloratadine is an antihistamine which is used for the symptomatic relief of allergic conditions including rhinitis and chronic urticaria. It does not readily enter the central nervous system, so does not cause drowsiness. |
| TCS 2510 | |
| N-stearyl-[Nle<sup>17</sup>]VIP | |
| enzastaurin | |
| LY-518674 | |
| UAMC00039 | |
| compound 16 (PMID:20947351) | |
| amisulpride | |
| sCKβ8-1 | |
| etidocaine | |
| [<sup>3</sup>H]rimonabant | |
| analog 3 | |
| trabectedin | A tetrahydroisoquinoline alkaloid obtained from a Caribbean tunicate Ecteinascidia turbinata. Used for the treatment of soft tissue sarcoma and relapsed ovarian cancer. |
| RS 57639 | |
| LY2365109 | |
| VU0357121 | |
| GW848687X | |
| [D-Phe<sup>6</sup> β-Ala<sup>11</sup> Phe<sup>13</sup> Nle<sup>14</sup>]bombesin-(6-14) | |
| [<sup>3</sup>H]2-furoyl-LIGRL-NH<sub>2</sub> | |
| SEW2871 | |
| ML 10302 | |
| [des-Arg<sup>10</sup>]icatibant | |
| NPY-(22-36) (pig) | |
| (3R 5S 6E)-7-[5-(4-fluorophenyl)-2-(propan-2-yl)-4-(pyridin-3-yl)-1H-imidazol-1-yl]-3 5-dihydroxyhept-6-enoate | |
| 15(<i>S</i>)-15-methyl-PGD<sub>2</sub> | |
| curcumin | A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa. |
| captopril | A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug. |
| GHRH-(1-29)-OH (human) | |
| procaine | A benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol. |
| [Leu<sup>31</sup> Pro<sup>34</sup>]PYY (human) | |
| butyric acid | A four-carbon straight-chain saturated fatty acid. |
| 15(<i>R</i>)-15-methyl-PGD<sub>2</sub> | |
| nefazodone | A triazole that has formula C25H32ClN5O2. |
| WAY-100635 | |
| compound 7 [PMID:20638279] | |
| NE58018 | |
| compound 15 (Hay <i>et al</i> 2013) | |
| neuromedin C (pig) | |
| NGB 2904 | |
| 2 2 2-TEMPS | |
| flupirtine | |
| AH23848 (racemic) | |
| [L-Tyr<sup>8</sup>]CYN 154806 | |
| ADX88178 | |
| CI-988 | |
| MRS2179 | |
| prenalterol | An aromatic ether that has formula C12H19NO3. |
| GSK1331258 | |
| [<sup>125</sup>I]L703 606 | |
| 7-trans-OH-PIPAT | |
| tazarotene | |
| palbociclib | |
| tryptamine | An aminoalkylindole consisting of indole having a 2-aminoethyl group at the 3-position. |
| verapamil | A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine. |
| [1-(hydroxycarbamoyl)-4-(3-phenoxyphenyl)butyl]phosphonate | |
| [Ile<sup>5</sup> Trp<sup>23</sup> Tyr<sup>36</sup>]PTHrP-(1-36)-NH<sub>2</sub> (human) | |
| [<sup>3</sup>H]PGF<sub>2α</sub> | |
| [<sup>3</sup>H]CNQX | |
| pizotifen | A benzocycloheptathiophene that is 9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophene 4-ylidene)-1-methylpiperidine which is joined from the 4 position to the 4 position of an N-methylpiperidine moiety by a double bond. It is a sedating antihistamine, with strong serotonin antagonist and weak antimuscarinic activity. It is generally used as the malate salt for the treatment of migraine and the prevention of headache attacks during cluster periods. |
| [<sup>125</sup>I]GIP | |
| TEI-9647 | |
| netupitant | |
| artepillin C | |
| NODAGA-[Tyr<sup>3</sup>]-octreotide | |
| 264W94 | |
| saxagliptin | |
| resolvin D1 | A very long-chain fatty acid that has formula C22H32O5. |
| azimilide | An imidazolidine-2,4-dione that has formula C23H28ClN5O3. |
| VU0238429 | |
| resolvin D2 | A very long-chain fatty acid that has formula C22H32O5. |
| M1160 | |
| NPS 2143 | |
| 17β-estradiol | The 17beta-isomer of estradiol. |
| 1 25-dihydroxyvitamin D3 | |
| (<i>S</i>)-5-iodowillardiine | |
| galanin(1-16) (rat/mouse/pig) | |
| L-arginine | An L-alpha-amino acid that is the L-isomer of arginine. |
| β-scorpion toxin Css IV | |
| 12-hydroxyheptadecatrienoic acid | |
| compound 36 (PMID: 24000170) | |
| AC-42 | |
| CP376395 | |
| F15599 | |
| 3-MATIDA | |
| TMFO1 | |
| piperidine-4-sulphonic acid | |
| VUF8507 | |
| S36539 | |
| lysophosphatidylethanolamine | A glycerophosphoethanolamine resulting from partial hydrolysis of a phosphatidylethanolamine, which removes one of the fatty acid groups. The structure is depicted in the image where R(1) = acyl, R(2) = H or where R(1) = H, R(2) = acyl. |
| [<sup>11</sup>C]pyrilamine | |
| SP600125 | |
| clonidine | |
| isradipine | |
| MK-499 | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP | |
| MK-6096 | |
| galanin(D-Trp<sup>2</sup>) (pig) | |
| [<sup>3</sup>H]CCK-8 (human mouse rat) | |
| FLTChaAR | |
| 5-fluorotryptamine | |
| fMet-Met-Tyr-Ala-Leu-Phe | |
| [<sup>3</sup>H]GR 113808 | |
| all-trans-4-oxo-retinoic acid | A retinoid that consists of all-trans-retinoic acid bearing an oxo substituent at position 4 on the cyclohexenyl ring. |
| VU0152100 | |
| dopamine | Catechol in which the hydrogen at position 4 is substituted by a 2-aminoethyl group. |
| [<sup>3</sup>H](+)-<i>cis</i>-diltiazem | |
| IRL 1620 | |
| [D-Trp<sup>2</sup>]galanin-(1–29) | |
| SM-130 686 | |
| [<sup>3</sup>H]CPP | |
| atosiban | |
| 4α-PDD | |
| (3R 5R)-7-[4-(4-fluorophenyl)-2 5-dimethyl-1-phenyl-1H-pyrrol-3-yl]-3 5-dihydroxyheptanoate | |
| E4031 | A sulfonamide that has formula C21H27N3O3S. |
| 4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide | |
| LTB<sub>4</sub> | |
| LY-465608 | |
| AGN192093 | |
| 2-[<sup>125</sup>I]MLT | |
| L-750 667 | |
| 4α-PDH | |
| [<sup>3</sup>H](+)DOB | |
| [<sup>125</sup>I]NDP-MSH | |
| JV-1-10 | |
| felodipine | The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris. |
| (-)-Ro 363 | |
| [<sup>125</sup>I]CCL8 (human) | |
| adenosine-3'-5'-bisphosphate | |
| panitumumab | |
| evatanepag | |
| [<sup>3</sup>H]OSIP339391 | |
| helodermin | |
| [<sup>125</sup>I]PD151242 | |
| [<sup>3</sup>H]N<sup>5</sup>-methylfolate | |
| lithocholic acid | A monohydroxy-5beta-cholanic acid with a alpha-hydroxy substituent at position 3. It is a bile acid obtained from chenodeoxycholic acid by bacterial action. |
| BIM28011 | |
| zinterol | |
| α-conotoxin PnIA | |
| apixaban | A pyrazolopyridine that is 7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide substituted at position 1 by a 4-methoxyphenyl group and at position 6 by a 4-(2-oxopiperidin-1-yl)phenyl group. It is used for the prevention and treatment of thromboembolic diseases. |
| 7-OH-DPAT | |
| JMV449 | |
| zoxazolamine | A benzoxazole that has formula C7H5ClN2O. |
| galanin(1-10) | |
| FR191413 | |
| d[<small>D</small>-Phe<sup>2</sup>]AVP | |
| hypoglaucin A | |
| tasimelteon | A member of the class of 1-benzofurans that is propionamide in which one of the amide hydrogens is replaced by a [(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl group. A melatonin receptor agonist used for the treatment of non-24-hour sleep-wake disorder. |
| levallorphan | |
| thiopental | A barbiturate, the structure of which is that of 2-thiobarbituric acid substituted at C-5 by ethyl and sec-pentyl groups. |
| Ga-NODAGA-LM3 | |
| abarelix | A polypeptide compound composed of ten natural and non-natural amino acid resiudes in a linear sequence. |
| [<sup>3</sup>H]YM298198 | |
| 2-bromo-N-[(2S 3S)-4-[2-(2 4-dichlorophenyl)ethyl-[3-(1 3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-[3-(phenoxy)phenyl]butan-2-yl]-4 5-dimethoxybenzamide | |
| dihydrocarveol | |
| neuropeptide-α | |
| 5-methyl nicotinic acid | |
| SB209712 | |
| bosentan | |
| LY303336 | |
| [<sup>125</sup>I]NPY | |
| [<sup>3</sup>H]CGS19755 | |
| azilsartan | |
| VUF 8430 | |
| P05 | |
| [<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Ile<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| reactive blue-2 | An anthraquinone that has formula C29H20ClN7O11S3. |
| 5-(6-chloro-2-hexyl-1H-indol-1-yl)-5-oxo-valeric acid | |
| LY320954 | |
| risedronate | |
| MRS1042 | |
| [<sup>3</sup>H]XAC | |
| SB-611812 | |
| M35 | |
| [Ala<sup>1 12</sup> Aib<sup>3</sup> Gln<sup>10</sup> hArg<sup>11</sup> Trp<sup>14</sup>]PTH-(1-14)-NH2 | |
| N/OFQ-(1-13)-NH<sub>2</sub> | |
| [<sup>3</sup>H](-)CGP 12177 | |
| PP-(13-36) (human) | |
| (+)-isradipine | |
| [<sup>111</sup>In <sup>90</sup>Y]DOTA-NOC | |
| [<sup>3</sup>H]muscimol | |
| TPA023 | |
| Ap<sub>4</sub>A | |
| 11-deoxy-PGE<sub>1</sub> | |
| neomycin | A broad-spectrum highly toxic antibiotic or mixture of antibiotics produced by a streptomyces (Streptomyces fradiae) and used medically especially to treat local infections. |
| [<sup>125</sup>I]BE-2254 | |
| analog 30 | |
| YM49598 | |
| cocaine | A tropane alkaloid obtained from leaves of the South American shrub Erythroxylon coca. |
| THIIC | |
| [Arg<sup>19</sup>]PTH-(1-34) (human) | |
| [Phaa<sup>1</sup> <small>D</small>-Tyr<sup>2</sup> Val<sup>4</sup> Arg<sup>6</sup> Arg-NH<sub>2</sub><sup>9</sup>]AVP | |
| (<i>R</i>)-α-methylhistamine | |
| oleoyl-thiophosphate | |
| 20-HETE | A HETE that consists of arachidonic acid bearing a hydroxy substituent at position 20. |
| UR-PG136 | |
| (3R 5R)-7-[1-cyclohexyl-4-(4-fluorophenyl)-2-(propan-2-yl)-1H-pyrrol-3-yl]-3 5-dihydroxyheptanoate | |
| [Sar<sup>1</sup> Ala<sup>8</sup>]Ang-II | |
| rolofylline | |
| atenolol | An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent. |
| hydroxyurea | A member of the class of ureas that is urea in which one of the hydrogens is replaced by a hydroxy group. An antineoplastic used in the treatment of chronic myeloid leukaemia as well as for sickle-cell disease. |
| RB-400 | |
| Gal-B2-C<sub>8</sub> | |
| trazodone | An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group. |
| CAY10583 | |
| zibotentan | |
| VU0366058 | |
| [des-Arg<sup>11</sup>]T-kinin | |
| rho-TIA | |
| [Ala<sup>31</sup> Aib<sup>32</sup>]NPY | |
| J-113397 | |
| spirapril | |
| diltiazem | A 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate in which both stereocentres have S configuration. A calcium-channel blocker and vasodilator, it is used as the hydrochloride in the management of angina pectoris and hypertension. |
| [<sup>3</sup>H]banyu (I) | |
| [<sup>3</sup>H]CCPA | |
| imidaprilat | |
| fluperlapine | A benzazepine that has formula C19H20FN3. |
| GW2433 | |
| [<sup>125</sup>I]sarafotoxin S6b | |
| orciprenaline | A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis. |
| VU0240382 | |
| [<sup>3</sup>H]Ro 63-0563 | |
| ruboxistaurin | |
| tenidap | A thiophene that has formula C14H9ClN2O3S. |
| heparin | A highly sulfated linear glycosaminoglycan comprising complex patterns of uronic acid-(1->4)-D-glucosamine repeating subunits. Used as an injectable anticoagulant, it has the highest negative charge density of any known biological molecule. |
| SB 612111 | |
| duramycin | A 19-membered heterodetic cyclic peptide that is isolated from Streptoverticillium cinnamoneus. It exhibits antiproliferative properties and induces apoptosis in tumour cells and has been used for treatment of cystic fibrosis. |
| TIPPψ | |
| AVT | A heterodetic cyclic peptide that is homologous to oxytocin and vasopressin. It is a pituitary hormone that acts as an endocrine regulator for water balance, osmotic homoeostasis and is involved in social and sexual behavior in non-mammalian vertebrates. |
| SSR126768A | |
| BPH-742 | |
| himbacine | A piperidine alkaloid that is decahydronaphtho[2,3-c]furan-1(3H)-one substituted by a methyl group at position 3 and a 2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl group at position 4. It has been isolated from the bark of Australian magnolias. |
| fenofibrate | A chlorobenzophenone that is (4-chlorophenyl)(phenyl)methanone substituted by a [2-methyl-1-oxo-1-(propan-2-yloxy)propan-2-yl]oxy group at position 1 on the phenyl ring. |
| farnesol | |
| (<i>S</i>)-α-methylhistamine | |
| [<small>D</small>-Bpa<sup>5</sup> Ile<sup>13</sup>]motilin (human) | |
| geraniol | A monoterpenoid consisting of two prenyl units linked head-to-tail and functionalised with a hydroxy group at its tail end. |
| [<sup>125</sup>I]GHRH (human) | |
| L-888 607 | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup>]OVT | |
| apomorphine | |
| [tBaa<sup>1</sup> <small>D</small>-Tyr(Et)<sup>2</sup> Val<sup>4</sup> Lys<sup>6</sup> Arg-NH<sub>2</sub><sup>8</sup> des-Gly<sup>9</sup>]AVP | |
| α5IA | |
| CHIPS | |
| lidocaine | The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline. |
| SB 203186 | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Ile<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| α-conotoxin AuIB | |
| LY134046 | |
| TAK-385 | |
| [<sup>3</sup>H]naltrindole | |
| [Tyr<sup>36</sup>]-PTHrP-(1-36) amide (human) | |
| adapalene | An adamantane that has formula C28H28O3. |
| 5BrUTP | |
| carbachol | An ammonium salt that has formula C6H15N2O2.Cl. |
| [<sup>3</sup>H]candesartan | |
| (+)-5-(5-bromothiophen-3-yl)-5-methyl-4-oxo-4 5-dihydro-furan-2-carboxylic acid | |
| dihydrokainate | |
| levodopa | |
| RO1138452 | |
| Des-AA<sup>1 2 5 12 13</sup>-[D-Trp<sup>8</sup>]SRIF | |
| colchicine | An alkaloid that is a carbotricyclic compound comprising 5,6,7,9-tetrahydrobenzo[a]heptalene having four methoxy substituents at the 1-, 2-, 3- and 10-positions as well as an oxo group at the 9-position and an acetamido group at the 7-position. It has been isolated from the plants belonging to genus Colchicum. |
| cerlapirdine | |
| 7α-NHMe-ginkgolide B | |
| dibutyl phthalate | |
| F180 | |
| hydrogen {2-[decyl(methyl)sulfaniumyl]-1-phosphonoethyl}phosphonate | |
| ω-agatoxin IIIA | |
| AC263093 | |
| BRL50481 | |
| cyclo apelin-12 (7-12) | |
| (3R 5R)-7-[3-(4-fluorophenyl)-8-oxo-7-phenyl-1-(propan-2-yl)-1H 4H 5H 6H 7H 8H-pyrrolo[2 3-c]azepin-2-yl]-3 5-dihydroxyheptanoate | |
| 4-(<i>n</i>-propyl)amino-3-nitrobenzoic acid | |
| promegestone | |
| ATPA | |
| KF26777 | |
| GT2394 | |
| methiothepin | A dibenzothiepine that is 10,11-dihydrodibenzo[b,f]thiepine bearing additional methylthio and 4-methylpiperazin-1-yl substituents at positions 8 and 10 respectively. Potent 5-HT2 antagonist, also active as 5-HT1 antagonist. Differentiates 5-HT1D sub-types. Also displays affinity for rodent 5-HT5B, 5-HT5A, 5-HT7 and 5-HT6 receptors (pK1 values are 6.6, 7.0, 8.4 and 8.7 respectively). |
| M1152 | |
| [<sup>125</sup>I]sauvagine (frog) | |
| 3-benzyl-4-(cyclopropyl-(4-(2 5-dichlorophenyl)thiazol-2-yl)amino)-4-oxobutanoic acid | |
| bufotenine | |
| cyclothiazide | |
| candoxitrilat | |
| [<sup>125</sup>I]SB-236636 | |
| isovelleral | An aldehyde that has formula C15H20O2. |
| lorazepam | |
| biperiden | |
| [<sup>3</sup>H]LXA<sub>4</sub> | |
| L-659 699 | |
| [<sup>3</sup>H]nicotinic acid | |
| analog 31 | |
| [<sup>3</sup>H]GR 125 743 | |
| enalapril | A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration). |
| vofopitant | |
| ephedrine | A phenethylamine alkaloid that is 2-phenylethanamine substituted by a methyl group at the amino nitrogen and a methyl and a hydroxy group at position 2 and 1 respectively. |
| rituximab | |
| GMQ | |
| charybdotoxin | |
| docetaxel | |
| trans flupenthixol | |
| 5S-HETE | A HETE having a (5S)-hydroxy group and (6E)-, (8Z)-, (11Z)- and (14Z)-double bonds. |
| [Bpa<sup>6</sup> Tyr<sup>10</sup>]secretin-27 (rat) | |
| ATC0175 | |
| PACAP-(6-38) | |
| TBPS | |
| compound 14c [PMID:18812259] | |
| compound 17 [PMID:17125263] | |
| adenosine | A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond. |
| 2-iodo-melatonin | |
| tiospirone | |
| 17-phenyl-<i>ω</i>-trinor-PGE<sub>2</sub> | |
| LY456066 | |
| SHAAGtide | |
| medica 16 | |
| J18 (galanin analogue) | |
| 3-(2 2-Bis-phosphono-ethyl)-5-decyloxy-1-methyl-pyridinium | |
| KB-R7943 | |
| compound 8 [PMID: 22533316] | |
| zacopride | |
| bambuterol | |
| dacomitinib | |
| MK-0249 | |
| WAY-100135 | |
| fampridine | |
| suprofen | |
| PTeB | |
| ASN04421891 | |
| Lei-Dab7 | |
| GHRP-6 | |
| triamcinolone | A C21-steroid hormone that is 1,4-pregnadiene-3,20-dione carrying four hydroxy substituents at positions 11beta, 16alpha, 17alpha and 21 as well as a fluoro substituent at position 9. Used in the form of its 16,17-acetonide to treat various skin infections. |
| Ga-KE88 | |
| FPTQ | |
| GHRP-2 | |
| S26284 | |
| I-BET-762 | |
| ASN04450772 | |
| tecalcet | |
| <i>cis</i>-3-ACPBPA | |
| LY341495 | |
| D-tryptophan | The D-enantiomer of tryptophan. |
| ocaperidone | |
| RS-25344 | |
| A-317920 | |
| clemastine | 2-[(2R)-1-Methylpyrrolidin-2-yl]ethanol in which the hydrogen of the hydroxy group is substituted by a 1-(4-chlorophenyl)-1-phenylethyl group (R configuration). An antihistamine with antimuscarinic and moderate sedative properties, it is used as its fumarate salt for the symptomatic relief of allergic conditions such as rhinitis, urticaria, conjunctivitis and in pruritic (severe itching) skin conditions. |
| (-)-EKC | |
| desvenlafaxine | |
| [<sup>3</sup>H]U69593 | |
| compound 4b | |
| P2pal18s | |
| SKF-105494 | |
| indole-3-propionic acid | |
| CP 93129 | |
| icatibant | |
| [<sup>11</sup>C]volinanserin | |
| tetronothiodin | |
| latanoprost (free acid form) | |
| istradefylline | |
| dabuzalgron | |
| FTY720-phosphate | |
| disulfiram | An organic disulfide that is 1,1'-[disulfanediylbis(carbonothioylimino)]diethane substituted by ethyl groups at the N atom. An EC 1.2.1.3 [aldehyde dehydrogenase (NAD+)] inhibitor, it is used as an alcohol deterrent. |
| lanosterol | A tetracyclic triterpenoid that is lanosta-8,24-diene substituted by a beta-hydroxy group at position 3. It is the compound from which all steroids are derived. |
| sphingosine | A sphing-4-enine in which the double bond is trans. |
| belatacept | |
| AFDX384 | A pyridobenzodiazepine that acts as a selective antagonist of the muscarinic acetylcholine receptors. |
| (+)-SKF-82526 | |
| ibudilast | |
| chloropicrin | A C-nitro compound that is nitromethane in which all three hydrogens are replaced by chlorines. It is a severe irritant, and can cause immediate, severe inflammation of the eyes, nose and throat, and significant injuries to the upper and lower respiratory tract. Formerly stockpiled as a chemical warfare agent, it has been widely used in the US as a soil fumigant, particularly for strawberry crops. It is not approved for use within the European Union. |
| SYM2081 | |
| U63640 | |
| GRI977143 | |
| [<sup>3</sup>H]CGS8216 | |
| nitrendipine | |
| SR11237 | |
| AMA | |
| MCH<sub>6-17</sub> | |
| clofibrate | A carboxylic ester that is the ethyl ester of clofibric acid. |
| 7 4'-dihydroxyisoflavone | |
| HIV-Tat | |
| St 587 | |
| mesoridazine | |
| 6-fluoromevalonate 5-diphosphate | |
| VU0364289 | |
| (5E)-octadec-5-en-7 9-diynoic acid | |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-4 7-dihydroxy-6-({[(11-phenoxyundecyl)oxy]carbonyl}oxy)-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| enoxaparin | |
| AG-26 | |
| cilazapril | |
| pentostatin | |
| [<sup>125</sup>I][D-Tyr<sup>6</sup>]bombesin-(6-13)-methyl ester | |
| L-703 606 | |
| [<sup>3</sup>H]d[Cha<sup>4</sup>]AVP | |
| tamoxifen | A stilbenoid that has formula C26H29NO. |
| SB452533 | |
| GR 125487 | |
| L-731120 | |
| (-)-chlorpheniramine | |
| R396 | |
| lubiprostone | |
| resolvin E1 | A leukotriene that has formula C20H30O5. |
| ω-agatoxin IVB | |
| ω-agatoxin IVA | |
| BQCA | |
| 2 2'-pyridylisatogen tosylate | |
| OSK1-K16-D20 | |
| A778317 | |
| [<sup>3</sup>H]folinic acid | |
| EPPTB | |
| SCH-23390 | A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1, a methyl substituent at position 3, a chloro substituent at position 7 and a hydroxy substituent at position 8. |
| SHU9119 | |
| pegvisomant | |
| varenicline | |
| ω-grammotoxin SIA | |
| MGS0028 | |
| tranylcypromine | An alkylamine that has formula C9H11N. |
| clorgiline | |
| [Asu7 23']β-ANP-(7-28) | |
| AS604872 | |
| indiplon | |
| GalR3ant | |
| JWH-133 | |
| calhex 231 | |
| NS1619 | A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca). |
| [<sup>3</sup>H]JNJ 7777120 | |
| ATX-II | |
| A-317567 | |
| (-)-baclofen | A monocarboxylic acid that is butanoic acid substituted by an amino group at position 4 and a 4-chlorophenyl group at position 3. It acts as a central nervous system depressant, GABA agonist and muscle relaxant. |
| D-phenylalanine | The D-enantiomer of phenylalanine. |
| beraprost | |
| OAADPR | |
| naloxonazine | |
| rhodamine123 | An organic chloride salt that has formula C21H17ClN2O3. |
| nolpitantium | |
| nalbuphine | An organic heteropentacyclic compound that has formula C21H27NO4. |
| vitamin D3 | |
| [<sup>125</sup>I][PP<sub>1-17</sub> Ala<sup>31</sup> Aib<sup>32</sup>]NPY (human) | |
| tesamorelin | |
| [Phe<sup>3</sup>]OT | |
| T140 | |
| (3R 5S 6E)-7-[4-(4-fluorophenyl)-2-[methyl(1-methyl-1H-1 2 3 4-tetrazol-5-yl)amino]-6-(propan-2-yl)pyrimidin-5-yl]-3 5-dihydroxyhept-6-enoate | |
| urantide | |
| S-14671 | |
| (RS)-5-diphosphomevalonate | |
| buserelin | |
| [<sup>3</sup>H]pyrilamine | |
| riluzole | |
| anandamide | A fatty amide obtained by the formal condensation of arachidonic acid with ethanolamine. |
| Ava3 | |
| 10-OBn-7α-F-gingkolide B | |
| LY2811376 | |
| (3S)-3-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)propanoic acid | |
| ethylestrenol | |
| nalmefene | |
| CV-3988 | |
| BQ123 | A cyclic peptide that has formula C31H42N6O7. |
| ICI 192605 | |
| RS-30199 | |
| 1-isopropylbenzotriazole-5-carboxylic acid | |
| mibolerone | An androgen that is nalandrone carrying two methyl substituents at positions 7alpha and 17. |
| MRS5151 | |
| [<sup>3</sup>H]devazepide | |
| [<sup>125</sup>I](Pyr<sup>1</sup>)apelin-13 | |
| 5β-cholestane-3α 7α 12α-triol | A 12alpha-hydroxy steroid that has formula C27H48O3. |
| moclobemide | |
| A61603 | |
| GSK Compound 34 | |
| 2-furoyl-LIGRLO-amide | |
| PSN632408 | |
| L-lysine | An L-alpha-amino acid; the L-isomer of lysine. |
| fluoxymesterone | An anabolic androgenic steroid that has formula C20H29FO3. |
| diphosphoric acid | An acyclic phosphorus acid anhydride obtained by condensation of two molecules of phosphoric acid. |
| rose bengal (photoactivated) | |
| YM44778 | |
| JNJ16259685 | |
| UDP-galactose | |
| (1S 3R 4aR 7S 8S 8aS)-3-hydroxy-8-{2-[(4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-7-methyl-1 2 3 4 4a 7 8 8a-octahydronaphthalen-1-yl (2S)-2-methylbutanoate | |
| befetupitant | |
| [<sup>111</sup>In]DOTA-NOC | |
| <i>p</i>-MPPI | |
| peginterferon alfa-2b | |
| AC-7954 | |
| palosuran | |
| Ac-DEVD-CHO | |
| JTC-801 | |
| A2P5P | |
| [Phe<sup>13</sup> Tyr<sup>19</sup>]MCH | |
| UCCF-029 | |
| ceritinib | A member of the class of aminopyrimidines that is 2,6-diamino-5-chloropyrimidine in which the amino groups at positions 2 and 6 are respectively carrying 2-methoxy-4-(piperidin-4-yl)-5-methylphenyl and 2-(isopropylsulfonylamino)phenyl substituents. Used for the treatment of ALK-positive metastatic non-small cell lung cancer. |
| diclofenamide | A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma. |
| GR159897 | |
| 5-(4-phenoxybutoxy)psoralen | |
| indisulam | |
| [Ala<sup>1 12</sup> Aib<sup>3</sup> Gln<sup>10</sup> hArg<sup>11</sup> Trp<sup>14</sup> Arg<sup>19</sup>]PTH-(1-28)-NH2 (human) | |
| INS48823 | |
| NE10790 | |
| [<sup>125</sup>I]aminopotentidine | |
| terutroban | |
| S36057 | |
| 5-ethyl-4-oxo-5-phenyl-4 5-dihydro-furan-2-carboxylic acid | |
| [nLeu<sup>13</sup> Glu<sup>14</sup>]motilin (human) | |
| α-conotoxin MI | |
| [<sup>3</sup>H]histidine | |
| YIL781 | |
| BI-2536 | |
| VU0469650 | |
| PF-04457845 | |
| <i>m</i>-CPP | |
| DIOA | |
| NF546 | |
| AYPGKF-NH2 | |
| imetit | An imidothiocarbamic ester that consists of isothiourea in which the thiol hydrogen is substituted by a 2-(imidazol-4-yl)ethyl group. An extremely potent, high affinity agonist at H3 and H4 receptors (Ki values are 0.3 and 2.7 nM respectively). Induces shape change in eosinophils with an EC50 of 25 nM. Centrally active following systemic administration. |
| Y27632 | A monocarboxylic acid amide that is trans-[(1R)-1-aminoethyl]cyclohexanecarboxamide in which one of the nitrogens of the aminocarbony group is substituted by a pyridine nucleus. It has been shown to exhibit inhibitory activity against Rho-associated protein kinase (ROCK) enzyme. |
| vMCC-I | |
| (-)-pentazocine | A benzazocine that has formula C19H27NO. |
| [<sup>125</sup>I]BIM23027 | |
| pyrilamine | |
| GYKI53655 | |
| CDDO-Me | |
| methacholine | |
| topiramate | A hexose derivative that is 2,3:4,5-di-O-isopropylidene-beta-D-fructopyranose in which the hydroxy group has been converted to the corresponding sulfamate ester. It blocks voltage-dependent sodium channels and is used as an antiepileptic and for the prevention of migraine. |
| MBP7 | |
| ONO-AE-248 | |
| L-731128 | |
| M-5MPEP | |
| decitabine | |
| [1 3-bis(2 4-dichlorophenyl)-2-phosphonopropan-2-yl]phosphonic acid | |
| SDZ 64-412 | |
| 1-methylcyclopropanecarboxylic acid | |
| BMS493 | |
| UFP-101 | |
| levomilnacipran | |
| Ag<sup>+</sup> | |
| Glaxo-11p | |
| BIM 23030 | |
| 5'-iodoresiniferatoxin | |
| NDT9520492 | |
| tranexamic acid | |
| MNI-137 | |
| salmeterol | |
| methylergonovine | |
| [(3-Ph-Pr<sup>6</sup>) His<sup>7</sup> D-Ala<sup>11</sup> D-Pro<sup>13</sup> ψ13-14) Phe<sup>14</sup>]bombesin-(6-14) | |
| veratridine | A steroid that has formula C36H51NO11. |
| ivermectin | A mixture consisting of >= 90% 22,23-dihydroavermectin B1a (R = Me) and <= 10% 22,23-dihydroavermectin B1b (R = H). A semi-synthetic derivative of abamectin, it is used as a broad-spectrum antiparasite medication, particularly against worms (except tapeworms), although it is also effective against most mites and some lice. |
| EBIO | |
| [<sup>125</sup>I]PYY | |
| EC18 | |
| EP 157 | |
| 9-hydroxyoctadecadienoic acid | |
| 2-APB | |
| ICI 118551 | An indane substituted at position 7 by a methyl group and at position 4 by a 3-(isopropylamino)-2-hydroxybutoxy group (the 2R,3S-diastereomer). |
| <i>trans</i>-3-ACPBPA | |
| [<sup>125</sup>I]gastrin | |
| DM-PPP | |
| DOG | |
| [<sup>3</sup>H]ketanserin | |
| nicorandil | |
| (±)YM796 | |
| D-AP4 | |
| clomiphene | A tertiary amine that has formula C26H28ClNO. |
| [<sup>125</sup>I]CXCL5 | |
| (4R)-6-[2-(4-fluorophenyl)-4 6-bis(propan-2-yl)phenoxymethyl]-4-hydroxyoxan-2-one | |
| [<sup>125</sup>I]kisspeptin-14 (human) | |
| sumanirole | |
| dexetimide | |
| T22 | |
| chroman 28 | |
| SZ(+)-(<i>S</i>)-202-791 | |
| [Ile<sup>5</sup> Trp<sup>23</sup>]PTHrP-(5-36) (human) | |
| MRK-1 | |
| MSOP | |
| iloprost | |
| octyl thiophosphatidic acid | |
| compound 1 [PMID: 22533316] | |
| Rec 15/2739 | |
| PF0998425 | |
| [D-Phe<sup>6</sup>]bombesin(6-13)methyl ester | |
| 3-amino-6 6-dimethyl-2-phenyl-8H-pyrano[4 5-e]pyridazine-4-carbonitrile | |
| ramucirumab | |
| galanin(1-19) (human) | |
| PD 176252 | |
| aplaviroc | |
| (+)-norfenfluramine | |
| aspirin | |
| anacardic acid | A hydroxybenzoic acid that has formula C22H36O3. |
| AM251 | |
| L-817 818 | |
| CCL20-SEAP(His)<sub>6</sub> | |
| KN62 | |
| MZ-4-71 | |
| L-363 301 | |
| mibefradil | |
| TC-5619 | |
| S6716 | |
| NAEPA | |
| L-741 626 | |
| A-119637 | |
| AM095 | |
| (R)-5-diphosphomevalonate | |
| 25-hydroxycholesterol | A 25-hydroxy steroid that has formula C27H46O2. |
| BIIE0246 | |
| XE991 | An anthracene that has formula C26H20N2O. |
| 24(S)-hydroxycholesterol | |
| 1-benzyl-N-(4-cyclohexylphenyl)-4-hydroxy-2-oxo-2 5-dihydro-1H-pyrrole-3-carboxamide | |
| RS-102895 | |
| [<sup>125</sup>I][Sar<sup>1</sup>]Ang-II | |
| sonepiprazole | |
| GR 218 231 | |
| 2MeSATP | |
| urotensin 1 (fish) | |
| iodoaminopotentidine | |
| Ki16425 | |
| AFD(R) | |
| aripiprazole | A quinolone that has formula C23H27Cl2N3O2. |
| SB 414240 | |
| pinacidil | |
| metoprolol | A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1. |
| compound 11d [PMID: 23981898] | |
| [<sup>125</sup>I]angiotensin-(1-7) | |
| L-368 930 | |
| [<sup>3</sup>H]CI977 | |
| AMPA | |
| 24(S) 25-epoxycholesterol | |
| R R-THC | |
| FK-480 | |
| B-9958 | |
| alendronate | |
| ABT-299 | |
| JMV180 | |
| L-glutamic acid | An optically active form of glutamic acid having L-configuration. |
| mocetinostat | |
| [<sup>125</sup>I]C5a (human) | |
| [<sup>3</sup>H]eprosartan | |
| [Ile<sup>5</sup> Glu<sup>19</sup>]PTHrP-(1-34) (human) | |
| [<sup>3</sup>H]DPDPE | |
| atorvastatin | A dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases. |
| [<sup>125</sup>I]chorionic gonadotropin (human) | |
| fulvestrant | |
| albiglutide | |
| dantrolene | The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. |
| RM65 | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Ile<sup>4</sup> Ala-NH<sub>2</sub><sup>9</sup>]AVP | |
| crofelemer | |
| S38151 | |
| fluticasone | |
| gemcitabine | A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. |
| NC 8-12 | |
| isoxazole azepine compound 3 | |
| 5-CT | |
| A412997 | |
| compound 9a [PMID: 22266036] | |
| benzylserine | |
| labetalol | A secondary amino compound formally derived from ammonia by replacing two of the hydrogens by 2-(3-carbamoyl-4-hydroxyphenyl)-2-hydroxyethyl and 4-phenylbutan-2-yl groups. It is an adrenergic antagonist used to treat high blood pressure. |
| rotigotine | |
| ARC-239 | |
| cyanopindolol | |
| onapristone | |
| [<sup>125</sup>I]α-bungarotoxin | |
| Rp-8-CPT-cGMPS | |
| PL017 | |
| TEI-9063 | |
| MGS0039 | |
| anti-BrP-LPA | |
| Ava5 | |
| Ba<sup>2+</sup> | |
| [<sup>11</sup>C]xanomeline | |
| [<sup>125</sup>I]CCL16 (human) | |
| S24773 | |
| PPADS | An azo compound that has formula C14H14N3O12PS2. |
| MF 498 | |
| hydroxycitronellal | The tertiary alcohol arising from addition of water across the C=C double bond of citronellal. |
| WAY200070 | |
| [Ava<sup>9 10</sup> Ava<sup>14 15</sup>]-Ac-hMCH<sub>6-16</sub>-NH2 | |
| PD 128907 | |
| rasagiline | |
| [Lys<sup>15</sup> Arg<sup>16</sup> Leu<sup>27</sup>]VIP-(1–7)/GRF-(8–27)-NH<sub>2</sub> | |
| MEN10627 | |
| [<sup>14</sup>C]metformin | |
| AM1241 | |
| MRS3558 | |
| DPCPX | An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group. |
| UTPγS | |
| GW803430 | |
| MTEB | |
| [<sup>3</sup>H]SSR149415 | |
| WIN35428 | |
| [<sup>125</sup>I]SQ-29548 | |
| 5-oxo-1-2-4-oxadiazol biphenyl | |
| [<sup>3</sup>H]HU-243 | |
| S22153 | |
| AR-C126313 | |
| AL-8810 | |
| cyanotriphenylborate | |
| nisoxetine | A secondary amino compound that is N-methyl-3-phenylpropan-1-amine substitued at position 3 by a 2-methoxyphenoxy group. |
| TIP39-(7-39) (mouse) | |
| epipregnanolone sulphate | |
| fondaparinux | A synthetic pentasaccharide which, apart from the O-methyl group at the reducing end of the molecule, consists of monomeric sugar units which are identical to a sequence of five monomeric sugar units that can be isolated after either chemical or enzymatic cleavage of the polymeric glycosaminoglycans heparin and heparan sulfate. |
| C089 | |
| [Leu<sup>13</sup>]motilin (human) | |
| (<i>S</i>)-4C3HPG | |
| anagrelide | A 1,5-dihydroimidazo[2,1-]quinazoline having an oxo substituent at the 2-position and chloro substituents at the 6- and 7-positions. |
| SR2640 | |
| mianserin | |
| testosterone propionate | A steroid ester that has formula C22H32O3. |
| 5-oxo-C20:3 | |
| [<sup>3</sup>H]folic acid | |
| ATC0065 | |
| [Gln<sup>8</sup>]GnRH | |
| mesalazine | |
| WB 4101 | |
| [His<sup>5</sup> <small>D</small>-Tyr<sup>6</sup>]GnRH | |
| phyllolitorin | |
| paracetamol | A phenol which has an acetamido substituent located para to the phenolic -OH group. |
| montelukast | An aliphatic sulfide that has formula C35H36ClNO3S. |
| GW7647 | A monocarboxylic acid that is 2-(phenylsulfanyl)isobutyric acid in which the phenyl group is substituted at the para- position by a 3-aza-7-cyclohexylhept-1-yl group in which the nitrogen is acylated by a (cyclohexylamino)carbonyl group. |
| amthamine | |
| chenodeoxycholyl-N<sup>ε</sup>-nitrobenzoxadiazol-lysine | |
| [<sup>125</sup>I]Tyr<sup>3</sup> SMS 201-995 | |
| 6-fluorotryptophan | |
| SiFA-Asn(AcNH-β-Glc)-Tyr³-octreotate | |
| vinpocetine | |
| SNC80 | |
| Gal-R2-dPEG<sub>24</sub> | |
| midazolam | |
| oxaprozin | |
| M1153 | |
| galanin(1-12) | |
| pindolol | A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol. |
| (+)-sulpiride | |
| senktide | |
| [<sup>33</sup>P]H2 relaxin | |
| A438079 | |
| bezafibrate | |
| basiliximab | |
| JV-1-41 | |
| [<sup>125</sup>I]PACAP-27 | |
| FK 224 | |
| NAAG | |
| (2S)-2-(2-benzyl-3-{[(1R)-1-{[(benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl}propanamido)-3-(1H-indol-3-yl)propanoic acid | |
| BI6015 | |
| AC-178 335 | |
| AG-14 | |
| M&B 28767 | |
| exendin-(9-39) | |
| teniposide | |
| 3-chlorotyrosine | |
| MRS2905 | |
| ezetimibe | A beta-lactam that is azetidin-2-one which is substituted at 1, 3, and 4 by p-fluorophenyl, 3-(p-fluorophenyl)-3-hydroxypropyl, and 4-hydroxyphenyl groups, respectively (the 3R,3'S,4S enantiomer). |
| exenatide | |
| VU0255035 | |
| CGP 56999A | |
| nandrolone | A 3-oxo Delta(4)-steroid that is estr-4-en-3-one substituted by a beta-hydroxy group at position 17. |
| ω-conotoxin GVIA | |
| T20(DP178) | |
| methylglyoxal | A 2-oxo aldehyde derived from propanal. |
| [<sup>3</sup>H]GSK931145 | |
| 7-hydroxycholesterol | |
| 1-OH-PGE<sub>1</sub> | |
| 4-[3-(2-fluorophenoxy)phenyl]-1-phosphonatobutane-1-sulfonate | |
| SB 215505 | |
| flavone | The simplest member of the class of flavones that consists of 4H-chromen-4-one bearing a phenyl substituent at position 2. |
| [Phe<sup>13</sup>]bombesin | |
| ranitidine | A member of the class of furans used to treat peptic ulcer disease (PUD) and gastroesophageal reflux disease. |
| CI-1015 | |
| paclitaxel | A tetracyclic diterpenoid isolated originally from the bark of the Pacific yew tree, Taxus brevifolia. It is a mitotic inhibitor used in cancer chemotherapy. Note that the use of the former generic name 'taxol' is now limited, as Taxol is a registered trade mark. |
| PSB-0739 | |
| dihydromorphine | A morphinane alkaloid that has formula C17H21NO3. |
| compound 10 [PMID: 15482908] | |
| [<sup>3</sup>H]dexamethasone | |
| thioperamide | A primary aliphatic amine that has formula C15H24N4S. |
| [Leu<sup>8</sup> des-Arg<sup>9</sup>]bradykinin | |
| MT-II | |
| 2-iodoacetamide | |
| diphenylboronic anhydride | |
| LY314228 | |
| (3R)-6-({3-[bis(4-fluorophenyl)methyl]-1-(propan-2-yl)naphthalen-2-yl}oxy)-3 5-dihydroxyhexanoate | |
| diprenorphine | A morphinane alkaloid that has formula C26H35NO4. |
| [<sup>3</sup>H]LTE<sub>4</sub> | |
| CID2440433 | |
| 5-butyl-1H-pyrazole-3-carboxylic acid | |
| (2S)-N-[(2S 3R)-1-cyclohexyl-4 4-difluoro-3-hydroxy-4-{[(2S)-2-methylbutyl]carbamoyl}butan-2-yl]-2-[(2S)-2-[(morpholine-4-sulfonyl)amino]-3-phenylpropanamido]pent-4-enamide | |
| pristanic acid | A branched, long-chain saturated fatty acid composed of pentadecanoic acid having methyl substituents at the 2-, 6-, 10- and 14-positions. |
| 5-oxo-12-HETE | |
| quipazine | |
| furosemide | A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure. |
| NF157 | |
| GSK 172981 | |
| putrescine | A four-carbon alkane-alpha,omega-diamine. It is obtained by the breakdown of amino acids and is responsible for the foul odour of putrefying flesh. |
| CJ-042794 | |
| CP-195543 | |
| SGC0946 | |
| 2-chloroadenosine | |
| 2-[4-(1 3-benzothiazol-2-yl)phenyl]-4-methylmorpholin-2-ol | |
| tositumomab | |
| SB 216641 | |
| ribavirin | A 1-ribosyltriazole that is the 1-ribofuranosyl derivative of 1,2,4-triazole-3-carboxamide. An inhibitor of HCV polymerase. |
| phenprocoumon | |
| compound (+)17a [PMID:20363624] | |
| DkTx | |
| dimethyl-W84 | |
| MRS4062 | |
| RP-69758 | |
| Ro 60-0175 | |
| [<sup>3</sup>H]RY80 | |
| teriparatide | |
| RF9 | |
| EXP3174 | |
| pravastatin | A carboxylic ester resulting from the formal condensation of (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin. |
| olodaterol | A member of the class of benzoxazine that is 6-hydroxy-1,4-benzoxazin-3-one in which the hydrogen at position 4 is replaced by a (1R)-1-hydroxy-2-{[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino}ethyl group. Used (as its hydrochloride salt) for long-term treatment of airflow obstruction in patients with chronic obstructive pulmonary disease including chronic bronchitis and/or emphysema. |
| glycopyrrolate | |
| VU0400195 | |
| asenapine | |
| famotidine | A guanidine that has formula C8H15N7O2S3. |
| [<sup>35</sup>S]non-peptide OT antagonist | |
| L-796 778 | |
| [p-aminoPhe6]ang II | |
| CID1792197 | |
| olvanil | |
| denopamine | |
| 2-amino-uridine-5'-monophosphate | |
| CP-481 715 | |
| RO5488608 | |
| pegfilgrastim | |
| RU28362 | |
| H<sup>+</sup> | |
| aspirin-triggered resolvin D1 | |
| indacaterol | |
| D-kynurenine | |
| europium-labelled H2 relaxin | |
| senicapoc | |
| U46619 | |
| SK1-I | |
| H3 relaxin analogue 3 | |
| N-[{3-(3-trifluoromethyl-4-fluorophenyl)isoxazol-5-yl}methyl]-4-([1 8]naphthyridin-2-yl)butyramide | |
| 13 14-dihydro-15-keto-PGD<sub>2</sub> | |
| 16 16-dimethyl-PGE<sub>2</sub> | |
| AUY954 | |
| SDZ-216525 | |
| Cs<sup>+</sup> | |
| nafarelin | |
| 8-OH-DPAT | A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively |
| 6-tert-butyl-<i>m</i>-cresol | |
| (-)-cyclazocine | |
| methyl salicylate | A benzoate ester that is the methyl ester of salicylic acid. |
| MRS1066 | |
| MRS1067 | |
| MRS1065 | |
| MRS1062 | |
| [<sup>125</sup>I]kisspeptin-10 (human) | |
| VU0092273 | |
| bicuculline | Bicuculline is a light-sensitive competitive antagonist of GABAA receptors. It was originally identified in 1932 in plant alkaloid extracts and has been isolated from Dicentra cucullaria, Adlumia fungosa, Fumariaceae, and several Corydalis species. |
| SB-649868 | |
| dNPA | |
| [Mpa<sup>1</sup> <small>D</small>-Tyr(Et)<sup>2</sup> <small>D</small>-Tic<sup>7</sup> <small>D</small>-Tic<sup>9</sup>]OT | |
| oxotremorine | A N-alkylpyrrolidine that has formula C12H18N2O. |
| [<sup>125</sup>I]Tyr<sup>11</sup>-SRIF-14 | |
| tezampanel | |
| GHRH-(1-29)-NH<sub>2</sub> (human) | |
| cetrorelix | |
| CD2665 | |
| JMV3008 | |
| aniracetam | |
| Met-Met-Trp-Leu-Leu | |
| L-163 101 | |
| galantamine | |
| AD-5061 | |
| [<sup>3</sup>H]digoxin | |
| milameline | |
| mevastatin | A carboxylic ester that is pravastatin that is lacking the allylic hydroxy group and in which the lactone moiety has been hydrolysed to the corresponding delta-hydroxy-carboxylic acid. A hydroxymethylglutaryl-CoA reductase inhibitor (statin) isolated from Penicillium citrinum and from Penicillium brevicompactum, its clinical use as a lipid-regulating drug ceased following reports of toxicity in animals. |
| PSB1114 | |
| EPZ004777 | |
| calcitriol-26 23-lactone | A steroid lactone that has formula C27H40O5. |
| CRA1000 | |
| 8-deoxy-neodysiherbaine | |
| quisqualate | |
| SB 206553 | A pyrroloindole that has formula C17H16N4O. |
| gaboxadol | |
| SB399885 | |
| [<sup>125</sup>I]CCL1 (human) | |
| (+)-chlorpheniramine | |
| isopulegol | |
| T0901317 | |
| YF-476 | |
| silahexocyclium | |
| β-FNA | A morphinane alkaloid that has formula C25H30N2O6. |
| [Ga-DOTA Tyr<sup>3</sup> Thr<sup>8</sup>]octreotide | |
| CP105696 | |
| 2-thioUTP | |
| (R)-N-oleoyltyrosinol | |
| {[hydroxy({[(2E 6Z)-3 7 11-trimethyldodeca-2 6 10-trien-1-yl]oxy}methyl)phosphoryl]methyl}phosphonic acid | |
| SMP-797 | |
| 7α 27-dihydroxycholesterol | |
| bromfenac | Amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure. |
| [<sup>125</sup>I]CXCL16 | |
| Pb<sup>2+</sup> | |
| esomeprazole | A 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole that has S configuration at the sulfur atom. An inhibitor of gastric acid secretion, it is used (generally as its sodium or magnesium salt) for the treatment of gastro-oesophageal reflux disease, dyspepsia, peptic ulcer disease, and Zollinger-Ellison syndrome. |
| [<sup>125</sup>I]INSL3 (human) | |
| BIM 23023 | |
| CPFPX | |
| ω-PnTx3-3 | |
| cilobradine | |
| [D-Trp<sup>11</sup>]neurotensin | |
| UDP-β-S | |
| fexofenadine | A piperidine-based anti-histamine compound. |
| mozavaptan | |
| VER-3323 | |
| TIP39-(7-39) (human/bovine) | |
| ATPγS | |
| [<sup>3</sup>H]d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP | |
| axitinib | |
| UDP | A pyrimidine ribonucleoside 5'-diphosphate that has formula C9H14N2O12P2. |
| [Leu<sup>8</sup>]-phyllolitorin | |
| VU0359516 | |
| NF449 | |
| (<i>RS</i>)-(tetrazol-5-yl)glycine | |
| histamine | A 1H-imidazol-4-yl group substituted at position C-4 by a 2-aminoethyl group. |
| RVX 208 | |
| compound 22d [PMID: 16242323] | |
| (5E 9E)-6 10 14-trimethyl-1-phosphonatopentadeca-5 9 13-triene-1-sulfonate | |
| JMV458 | |
| spiroxatrine | |
| [<sup>3</sup>H]SR49059 | |
| silodosin | |
| [D-Pro<sup>4</sup> D-Trp<sup>7 9 10</sup>]substance P (4-11) | |
| L-797 591 | |
| [<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup> Val<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| N-{3-[(3R)-5-amino-3-methyl-3 6-dihydro-2H-1 4-oxazin-3-yl]-4-fluorophenyl}-5-chloro-3-methylpyridine-2-carboxamide | |
| linsitinib | |
| WWGKKYRASKLGLAR | |
| [<sup>35</sup>S]ibutamoren | |
| pyrrolopyrimidine 48 | |
| mecamylamine | |
| (+)-<i>cis</i>-H<sub>2</sub>-PAT | |
| rivaroxaban | |
| MRS1486 | |
| Sch 202596 | |
| daratumumab | |
| DC 23-60 | |
| nifedipine | A dihydropyridine that has formula C17H18N2O6. |
| Hg<sup>2+</sup> | |
| [<sup>111</sup>In <sup>90</sup>Y]DOTA-OC | |
| flumazenil | A 1,4-benzodiazepine that has formula C15H14FN3O3. |
| nalfurafine | |
| K41498 | |
| chlorobenzylidene malononitrile | |
| terbutaline | A member of the class of phenylethanolamines that is catechol substuted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group. |
| irbesartan | |
| grifolic acid methyl ether | |
| tacalcitol | |
| SDF-1 1-9[P2G] dimer | |
| hyperforin | A sesquarterpenoid that has formula C35H52O4. |
| phenylglycine-01 | |
| ARP100 | |
| BMS-561392 | |
| NPY-(16-36) (pig) | |
| sumatriptan | A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). |
| CFTR<sub>inh</sub>-172 | |
| R5-HIV-1 gp120 | |
| ME67 | |
| β-scorpion toxin Cn2 | |
| [<sup>3</sup>H]alniditan | |
| AH23848 | |
| [N-Me des-Sar]Gal-B2 | |
| KRP 203-phosphate | |
| [<sup>33</sup>P]2MeSADP | |
| [<sup>125</sup>I][cPP(1-7) NPY(19-23) Ala<sup>31</sup> Aib<sup>32</sup> Gln<sup>34</sup>]hPP | |
| MZ-4-243 | |
| WAY-207024 | |
| [(pF)Phe<sup>4</sup>]N/OFQ-(1-13)-NH<sub>2</sub> | |
| WIN 62 577 | |
| piperine | A N-acylpiperidine that is piperidine substituted by a (1E,3E)-1-(1,3-benzodioxol-5-yl)-5-oxopenta-1,3-dien-5-yl group at the nitrogen atom. It is an alkaloid isolated from the plant Piper nigrum. |
| TAK-220 | |
| ML9 | |
| Trp<sup>11</sup>-neurotensin | |
| SB202190 | A member of the class of imidazoles that is 1H-imidazole in which the hydrogens at positions 2, 4, and 5 are replaced by 4-hydroxyphenyl, pyridin-4-yl, and 4-fluorophenyl groups, respectively. It is a widely used inhibitor of mitogen-activated protein kinase (MAPK) alpha and beta. |
| TUG-770 | |
| misoprostol (free acid form) | |
| SCH 37370 | |
| SB 228357 | An indolyl carboxylic acid that has formula C22H17F4N3O2. |
| DCDPC | |
| HMR-1556 | A 1-benzopyran that has formula C15H20N2O4S. |
| 1-palmitoyl-lysophosphatidylcholine | |
| Rhodei-litorin | |
| NIP-142 | |
| SB-706375 | |
| Z-WEHD-FMK | |
| MC148R | |
| L-362 855 | |
| peginesatide | |
| [<sup>125</sup>I]PP (human) | |
| [<sup>3</sup>H]SCH 58261 | |
| SR59230A | |
| [Nle<sup>8 18</sup> Tyr<sup>34</sup>]PTH-(1-34)-NH<sub>2</sub> (bovine) | |
| pralatrexate | |
| F2L-[<sup>125</sup>I]Tyr | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Ile<sup>4</sup>]AVP | |
| MRS2365 | |
| PAT5A | |
| TC14012 | |
| GIP-(10-30) | |
| BC-254 | |
| lacosamide | |
| valsartan | |
| desipramine | A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group. |
| aflibercept | |
| Ro20-1724 | |
| ORG2058 | |
| ofatumumab | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup> Phe(3<sup>125</sup>I 4N<sub>3</sub>)-NH<sub>2</sub><sup>9</sup>]OVT | |
| NPY-(26-36) (pig) | |
| LG100268 | |
| 2-MPP | |
| 13 14-dihydro-16-<i>m</i>-chlorophenoxy-<i>w</i>-tetranor-PGF<sub>1α</sub> | |
| AGN193109 | |
| promazine | |
| AS1907417 | |
| correolide | A hydroxy steroid that has formula C40H52O15. |
| BOC-ATE | |
| 7α-NH<sub>2</sub>-ginkgolide B | |
| [<sup>3</sup>H]4NMPB | |
| FR-181157 | |
| levocabastine | |
| visnagin | An oxacycle that has formula C13H10O4. |
| [<sup>125</sup>I][Leu<sup>31</sup> Pro<sup>34</sup>]NPY | |
| lithocholylcholine | |
| aminobenzovesamicol | |
| dioctanoy​lglycerol​ pyrophos​phate | |
| AZD6538 | |
| practolol | |
| [<small>L</small>-Bpa<sup>5</sup> Ile<sup>13</sup>]motilin (human) | |
| 4-(9-ethyl-9H-carbazol-3-yl)-1-phosphonatobutane-1-sulfonate | |
| PAMP-12 (human) | |
| cilostamide | |
| AM281 | |
| tannic acid | |
| Teijin-lead_cmp_5 | |
| monomethylfumarate | |
| (<i>R S</i>)-PHPNECA | |
| LY-510929 | |
| VU0285683 | |
| genistein | 7-Hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties. |
| AMN082 | |
| antisauvagine | |
| [<sup>14</sup>C]acetylCoA | |
| sertraline | A member of the class of tetralins that is tetralin which is substituted at positions 1 and 4 by a methylamino and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as the hydrochloride salt as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder. |
| E339-3D6 | |
| [D-Ala<sup>2</sup>]deltorphin I | |
| S26131 | |
| NE10575 | |
| OL135 | |
| RO5166017 | |
| [<sup>3</sup>H]eletriptan | |
| L-367 938 | |
| compound 17 [PMID: 15300839] | |
| FL104 | |
| [<sup>125</sup>I]SHU9119 | |
| compound 27 [PMID:20346665] | |
| NCFP | |
| BCTC | |
| tacrine | |
| bromocriptine | An indole alkaloid that has formula C32H40BrN5O5. |
| [<sup>3</sup>H]R214127 | |
| Hp(2-20) | |
| GSK931145 | |
| clotrimazole | A member of the class of imidazoles that is 1H-imidazole in which the hydrogen attached to a nitrogen is replaced by a monochlorotrityl group. |
| suramin | |
| NE58043 | |
| rilonacept | |
| atomoxetine | A secondary amino compound having methyl and 3-(2-methylphenoxy)-3-phenylpropan-1-yl substituents. |
| TC-2403 | |
| FR194921 | |
| 15S-HPETE | The (S)-enantiomer of 15-HPETE. |
| [<sup>125</sup>I]thyroxine | |
| alkyl OMPT | |
| [D-Trp<sup>8</sup>]γ-MSH | |
| binodenoson | |
| A-794282 | |
| [D-Trp<sup>12</sup> Tyr<sup>34</sup>]PTH-(7-34) (bovine) | |
| [Ser<sup>8</sup>]GnRH | |
| dabigatran | An aromatic amide obtained by formal condensation of the carboxy group of 2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazole-5-carboxylic acid with the secondary amoino group of N-pyridin-2-yl-beta-alanine. The active metabolite of the prodrug dabigatran etexilate, it acts as an anticoagulant which is used for the prevention of stroke and systemic embolism. |
| PF-543 | |
| [<sup>125</sup>I]iodovinyl-TBZ | |
| [<sup>125</sup>I]ABOPX | |
| bromo-deaza-SAH | |
| daltroban | |
| (±)-<i>cis</i>-2-CAMP | |
| MRS2279 | |
| [<sup>3</sup>H]MRS2279 | |
| (3R 5S 6E)-7-[1-cyclohexyl-4-(4-fluorophenyl)-2-(propan-2-yl)-1H-pyrrol-3-yl]-3 5-dihydroxyhept-6-enoate | |
| SNAP-7941 | |
| indanidine | |
| compound 4d (PMID: 21851057) | |
| zalospirone | |
| BAY27-9955 | |
| iturelix | |
| compound 6o [PMID:19524438] | |
| compound 4a | |
| ADX-47273 | |
| [<sup>125</sup>I]XCL1 | |
| wortmannin | A delta-lactone that has formula C23H24O8. |
| [<sup>2</sup>Ala]-galparan | |
| reglitazar | |
| picrotoxin | |
| GSK575594A | |
| RS67506 | An aromatic ether that is the 3,5-dimethoxybenzyl derivative of N-(2-{4-[3-(4-amino-5-chloro-2-hydroxyphenyl)-3-oxopropyl]piperidin-1-yl}ethyl)methanesulfonamide. A potent and selective 5-HT4 antagonist, with a pKi of 9.1 at 5-HT4 receptors in guinea pig striatal membranes and greater than 1000-fold selectivity over 5-HT1A, 2C, 3 and D1, D2, M1, M2, AT1, B1 and alpha1C receptors. The ketone group gives RS 39604 a relatively long half life; it is also orally active and so suitable for in vivo studies. |
| Ac-GRP-(20-26)-methylester | |
| L-AP4 | |
| 1-arylmethylpyrrolidin-2-yl ethanol amine | |
| alemtuzumab | |
| afatinib | A quinazoline compound having a 3-chloro-4-fluoroanilino group at the 4-position, a 4-dimethylamino-trans-but-2-enamido group at the 6-position, and an (S)-tetrahydrofuran-3-yloxy group at the 7-position. Used (as its dimaleate salt) for the first-line treatment of patients with metastatic non-small cell lung cancer. |
| DADLE | |
| NN-dimethyl-D-erythrosphingosine | |
| N-oleoyldopamine | A fatty amide that has formula C26H43NO3. |
| S20928 | |
| decavanadate | |
| PYY-(3-36) (pig) | |
| isoguvacine | A tetrahydropyridine that has formula C6H9NO2. |
| perindoprilat | |
| 4-{dimethyl[5-(4-phenylphenyl)pentyl]azaniumyl}butane-1-sulfonate | |
| atopaxar | |
| cortisol | A C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the stress hormone as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses |
| PG 97-269 | |
| LY301875 | |
| BPH-715 | |
| leuprolide | An oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, D-leucyl, leucyl, arginyl, and N-ethylprolinamide residues joined in sequence. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant (particularly as the acetate salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty. |
| [<sup>3</sup>H]nemonapride | |
| conivaptan | |
| ponatinib | |
| HTMT | |
| difluprednate | |
| forasartan | |
| venlafaxine | A tertiary amino compound that is N,N-dimethylethanamine substituted at position 1 by a 1-hydroxycyclohexyl and 4-methoxyphenyl group. |
| melagatran | A member of the class of azetidines that is (2S)-azetidine 2-carboxylic acid in which the carboxylic acid has been converted to the amide corresponding to formal condensation with 4-(aminomethyl)benzenecarboximidamide and in which the hydrogen attached to the azetidine nitrogen is replaced by a (2R)-2-cyclohexyl-2-[(carboxymethyl)amino]acetyl group. |
| β-phenylethylamine | |
| <i>N</i>-methylhistamine | |
| [<sup>3</sup>H]OT (human mouse rat) | |
| [Ile<sup>5</sup>]PTHrP-(1-36) (human) | |
| [Arg<sup>16</sup>]chicken secretin | |
| pazopanib | |
| [<sup>125</sup>I]ZM-241385 | |
| [<sup>3</sup>H]cytisine | |
| 7-fluorochromone-2-carboxamide | |
| peptidoglycan | A glycosaminoglycan formed by alternating residues of D-glucosamine and either muramic acid {2-amino-3-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose} or L-talosaminuronic acid (2-amino-2-deoxy-L-taluronic acid), which are usually N-acetylated or N-glycoloylated. The carboxyl group of the muramic acid is commonly substituted by a peptide containing residues of both L- and D-amino acids, whereas that of L-talosaminuronic acid is substituted by a peptide consisting of L-amino acids only. |
| vilazodone | |
| farglitazar | |
| reboxetine | |
| MPEP | |
| LUF5831 | |
| E55888 | |
| (1S 2S 3S 4S)-3 4-bis({butyl[(4-phenoxyphenyl)methyl]carbamoyl})cyclobutane-1 2-dicarboxylic acid | |
| ICI 169369 | |
| 2' 3'-ddATP | |
| compound 11a [PMID: 14697765] | |
| dilazep | |
| [<sup>3</sup>H]SB-674042 | |
| [<sup>125</sup>I][Tyr<sup>26</sup>]galanin (human) | |
| beclometasone dipropionate | |
| U46609 | |
| CGP37849 | |
| paroxetine | A benzodioxole that consists of piperidine bearing 1,3-benzodioxol-5-yloxy)methyl and 4-fluorophenyl substituents at positions 3 and 4 respectively; the (3S,4R)-diastereomer. Highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki values are 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Displays minimal affinity for alpha1-, alpha2- or beta-adrenoceptors, 5-HT2A, 5-HT1A, D2 or H1 receptors at concentrations below 1000 nM, however displays weak affinity for muscarinic ACh receptors (Ki = 42 nM). Antidepressant and anxiolytic in vivo. |
| alfuzosin | A tetrahydrofuranol that has formula C19H27N5O4. |
| compound 23 [PMID: 17590335] | |
| BX 667 | |
| galanin(7-29) (pig) | |
| TG-101348 | |
| VPC44116 | |
| methyl 4-[4-(2-{3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl}ethynyl)-3-(prop-2-en-1-yl)phenyl]butanoate | |
| I-BOP | |
| propanoic acid | |
| [<sup>3</sup>H]kainate | |
| NS309 | |
| L023103 | |
| [<sup>3</sup>H]S0139 | |
| moexipril | |
| sivelestat | |
| ethyl 2-[4-(2-{3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl}ethynyl)phenyl]acetate | |
| MSVIII-19 | |
| grifolic acid | |
| pemetrexed | |
| diphenhydramine | An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug. |
| VU0240551 | |
| frovatriptan | |
| CGS 24012 | |
| [(2S 3aS 7aS)-2-(1 3-thiazolidine-3-carbonyl)-2 3 3a 4 5 6 7 7a-octahydroindol-1-yl]-[(1R 2R)-2-phenylcyclopropyl]methanone | |
| bevacizumab | |
| α-scorpion toxin | |
| eticlopride | |
| flecainide | |
| latanoprost (isopropyl ester) | |
| BMS compound 87b | |
| [<sup>3</sup>H]MRS1754 | |
| L-165461 | |
| barasertib-hQPA | |
| [<sup>123</sup>I]AM251 | |
| ICI 174 864 | |
| PHTPP | |
| 12S-HPETE | The (S)-enantiomer of 12-HPETE. |
| [<sup>3</sup>H]Ro154513 | |
| MPC-MECA | |
| [<sup>3</sup>H]R1881 | |
| desoximetasone | Dexamethasone in which the hydroxy group at the 17alpha position is substituted by hydrogen. A synthetic corticosteroid with glucocorticoid activity, it is used as an anti-inflammatory and anti-pruritic in the treatment of various skin disorders, including skin allergies and psoriasis. |
| BPH-628 | |
| [D-Phe<sup>6</sup> Cpa<sup>14</sup> ψ13-14]bombesin-(6-14) | |
| pioglitazone | A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity. |
| (D-Ala<sup>11</sup>]bombesin | |
| [Trp<sup>8</sup>]GnRH | |
| 19(<i>R</i>)-OH-PGE<sub>2</sub> | |
| retinol | A retinoid consisting of 3,7-dimethylnona-2,4,6,8-tetraen-1-ol substituted at position 9 by a 2,6,6-trimethylcyclohex-1-en-1-yl group (geometry of the four exocyclic double bonds is not specified). |
| azidopine | A benzamide that has formula C27H26F3N5O5. |
| L-369 020 | |
| 6-fluoro-noradrenaline | |
| FR173657 | |
| [<sup>125</sup>I]Tyr<sup>7</sup>-Sst3-ODN-8 | |
| GR-55562 | |
| testolactone | |
| [<sup>125</sup>I]SDF-1β (human) | |
| [<sup>3</sup>H]Lys-[des-Arg<sup>9</sup>]BK | |
| isothiourea-1t | |
| motilin-(1-13) (human) | |
| geranyl biphosphonate | |
| Ro 25-1553 | |
| IKs124 | |
| citral | |
| NaHS | |
| sildenafil | |
| saralasin | |
| L-363 409 | |
| spironolactone | A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7. |
| avagacestat | |
| PHA-543613 | |
| P'-geranyl 3 5 7-trihydroxy-3-methylheptanate 7-diphosphate | |
| BW723C86 | |
| SB-219994 | |
| SB-219993 | |
| (3R 6E)-7-[6-chloro-4-(4-fluorophenyl)-2-(propan-2-yl)quinolin-3-yl]-3 5-dihydroxyhept-6-enoate | |
| 2-({[(3-{[(2E)-3 7-dimethylocta-2 6-dien-1-yl]oxy}phenyl)methyl]carbamoyl}(hydroxy)amino)-2-methylpropanoate | |
| compound 23 [PMID:21444206] | |
| JMV594 | |
| 2-methyl-2-propanyl 1'-(3-pyridinyl)-4 4'-bipiperidine-1-carboxylate | |
| BIM 23050 | |
| sarpogrelate | |
| 3-bromo-7NI | |
| [Sar<sup>1</sup> Cha<sup>8</sup>]Ang-II | |
| XD14 | |
| fenoterol | |
| [<sup>125</sup>I][Nle<sup>8 21</sup> Tyr<sup>34</sup>]PTH-(1-34)-NH<sub>2</sub> (rat) | |
| [<sup>3</sup>H]iloprost | |
| compound 27 [PMID: 20598884] | |
| dolichol phosphate | |
| antarelix | |
| 5PAM523 | |
| (3S)-4-{[(E)-2-[1-(4-fluorophenyl)-3-(propan-2-yl)-1H-indol-2-yl]ethenyl](hydroxy)phosphoryl}-3-hydroxybutanoic acid | |
| erlotinib | |
| L-aspartate | An aspartate(2-) that is the conjugate base of L-aspartate(1-). |
| tertatolol | |
| LP-403812 | |
| niflumic acid | |
| [<sup>3</sup>H]AF DX-384 | |
| GALP(1-32) (human) | |
| BMS pyrazole inhibitor 7f | |
| [<sup>3</sup>H]N/OFQ | |
| prucalopride | |
| (des 1-8) A-chain INSL3 analogue | |
| [<sup>3</sup>H]LSD | |
| X4-HIV-1 gp120 | |
| MK 0354 | |
| compound 29 [PMID:17064898] | |
| infliximab | |
| P'-geranyl 2-fluoromevalonate 5-diphosphate | |
| 3 5-dimethyl PPP | |
| 2-pyridylethylamine | An aminoalkylpyridine that is pyridine substituted by a ethanamino group at position 2. |
| linoleic acid | An octadecadienoic acid in which the two double bonds are at positions 9 and 12 and have Z (cis) steeochemistry. |
| [<sup>3</sup>H]S-145 | |
| [<sup>3</sup>H]zolpidem | |
| super cinnamaldehyde | |
| [<sup>125</sup>I]TSH | |
| DMCM | |
| ML204 | |
| 4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-1-(1 3-dihydroisoindol-2-yl)butane-1 4-dione | |
| i-Boc-Met-Leu-Phe | |
| MCCG | |
| CL82198 | |
| chlorothiazide | 4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension. |
| UTP | A pyrimidine ribonucleoside 5'-triphosphate having uracil as the nucleobase. |
| L-CCG-I | |
| (R)-PIA | |
| diflorasone diacetate | The 17,21-diacetate derivative of diflorasone. It is used topically for its anti-inflammatory and antipruritic properties in the treatment of various skin disorders. |
| [<sup>3</sup>H]SQ-29548 | |
| eflornithine | |
| TFLLR-NH<sub>2</sub> | |
| iloperidone | |
| α-conotoxin TxIA | |
| RWJ-56110 | |
| compound 4b [PMID:16099654] | |
| glibenclamide | |
| t-Boc-Met-Leu-Phe | |
| T21/DP107 | |
| GSK2606414 | |
| KOS1326 | |
| Ro64-6198 | |
| sphingosine kinase inhibitor | |
| B-9858 | |
| YSFKPMPLaR | |
| F peptide | |
| (4S 6S)-6-{2-[1-benzyl-5-(4-fluorophenyl)-3-(propan-2-yl)-1H-pyrazol-4-yl]ethyl}-4-hydroxyoxan-2-one | |
| [<sup>125</sup>I]ET-1 | |
| <i>S</i>-OOPP | |
| SEAP-XCL1 | |
| NS-220 | |
| MRS1088 | |
| escitalopram | |
| [<sup>125</sup>I]APNEA | |
| BTP2 | |
| Ip<sub>5</sub>I | |
| NAD | |
| L-366 682 | |
| [Bpa<sup>1</sup> Ile<sup>13</sup>]motilin (human) | |
| L-citrulline | The L-enantiomer of citrulline. |
| gemtuzumab ozogamicin | |
| compound 3 [PMID:21310611] | |
| GW1100 | |
| formoterol | |
| [<sup>3</sup>H]alanine | |
| A-794278 | |
| fasidotrilat | |
| (D-Thr<sup>6</sup> D-Trp<sup>8 9</sup>)galanin(1-15)ol | |
| ketamine | A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group. |
| 3-hydroxy-3-methyl-6-phosphohexanoic acid | |
| I-SAP | |
| TRV120027 | |
| L838417 | |
| SKF 89748 | |
| [des-Gly<sup>10</sup> <small>D</small>-Ala<sup>6</sup>]GnRH <i>N</i>-ethylamide | |
| VU0029767 | |
| WAY170523 | |
| imidapril | |
| RU 24969 | |
| Abbott 14c | |
| d-AP5 | |
| aclidinium | |
| SF-01 | |
| AC262970 | |
| PNU-282987 | |
| (+)-SCH-23390 | A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1, a methyl substituent at position 3, a chloro substituent at position 7 and a hydroxy substituent at position 8. |
| R214127 | |
| aconitine | A diterpenoid that is 20-ethyl-3alpha,13,15alpha-trihydroxy-1alpha,6alpha,16beta-trimethoxy-4-(methoxymethyl)aconitane-8,14alpha-diol having acetate and benzoate groups at the 8- and 14-positions respectively. |
| NPY-(18-36) (human pig) | |
| flunisolide | A cyclic ketal that has formula C24H31FO6. |
| IIK7 | |
| 2-(3-iodophenyl)histamine | |
| pseudechetoxin | |
| 12R-HETE | A HETE having a (12R)-hydroxy group and (5Z)-, (8Z)-, (10E)- and (14Z)-double bonds. |
| 2-(3-bromophenyl)histamine | |
| buspirone | An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the nitrogen atom. |
| alpha1-proteinase inhibitor | |
| osanetant | |
| [<sup>125</sup>I][Glp<sup>65</sup>Nle<sup>75</sup> Tyr<sup>77</sup>]apelin-13 | |
| PPTN | |
| BrP-LPA | |
| W54011 | |
| [Sar<sup>1</sup> Cha<sup>4</sup>]Ang-II | |
| compound 19 [PMID:18812259] | |
| erythromycin-A | An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively. |
| [<sup>3</sup>H]BSP | |
| [<sup>3</sup>H]ZM 241385 | |
| 2-oleoyl-LPA | |
| scriptaid | |
| H<sub>2</sub>O<sub>2</sub> | |
| Ro19-4603 | An organosulfur heterocyclic compound that has formula C15H17N3O3S. |
| 3 5-DHPG | |
| [<sup>14</sup>C]GlySar | |
| maurotoxin | |
| enadoline | |
| fluparoxan | |
| GW9578 | |
| PA451 | |
| drotrecogin alfa | |
| quinine | A cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy. |
| CGEN-856 | |
| SKF-75670 | |
| 6-n-octylaminouracil | |
| [<sup>3</sup>H]SP (human mouse rat) |
